Illumina Body Map 2: averaged replicates
Gene Symbol | Gene ID | Gene Info |
---|---|---|
IRF2
|
ENSG00000168310.6 | interferon regulatory factor 2 |
STAT2
|
ENSG00000170581.9 | signal transducer and activator of transcription 2 |
IRF8
|
ENSG00000140968.6 | interferon regulatory factor 8 |
IRF1
|
ENSG00000125347.9 | interferon regulatory factor 1 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
IRF1 | hg19_v2_chr5_-_131826457_131826514 | 0.69 | 1.5e-05 | Click! |
IRF2 | hg19_v2_chr4_-_185395672_185395734 | 0.68 | 2.2e-05 | Click! |
IRF8 | hg19_v2_chr16_+_85942594_85942635 | 0.67 | 2.8e-05 | Click! |
STAT2 | hg19_v2_chr12_-_56753858_56753930 | 0.44 | 1.2e-02 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr12_+_113416191 | 18.09 |
ENST00000342315.4
ENST00000392583.2 |
OAS2
|
2'-5'-oligoadenylate synthetase 2, 69/71kDa |
chr7_+_74188309 | 17.79 |
ENST00000289473.4
ENST00000433458.1 |
NCF1
|
neutrophil cytosolic factor 1 |
chrX_+_37639302 | 16.11 |
ENST00000545017.1
ENST00000536160.1 |
CYBB
|
cytochrome b-245, beta polypeptide |
chr12_+_113416340 | 15.95 |
ENST00000552756.1
|
OAS2
|
2'-5'-oligoadenylate synthetase 2, 69/71kDa |
chr16_+_12058961 | 14.91 |
ENST00000053243.1
|
TNFRSF17
|
tumor necrosis factor receptor superfamily, member 17 |
chr16_+_57023406 | 14.37 |
ENST00000262510.6
ENST00000308149.7 ENST00000436936.1 |
NLRC5
|
NLR family, CARD domain containing 5 |
chr12_+_113416265 | 13.81 |
ENST00000449768.2
|
OAS2
|
2'-5'-oligoadenylate synthetase 2, 69/71kDa |
chr7_+_150382781 | 13.46 |
ENST00000223293.5
ENST00000474605.1 |
GIMAP2
|
GTPase, IMAP family member 2 |
chr17_-_4643114 | 13.21 |
ENST00000293778.6
|
CXCL16
|
chemokine (C-X-C motif) ligand 16 |
chrX_+_37639264 | 13.12 |
ENST00000378588.4
|
CYBB
|
cytochrome b-245, beta polypeptide |
chr16_-_67970990 | 12.91 |
ENST00000358514.4
|
PSMB10
|
proteasome (prosome, macropain) subunit, beta type, 10 |
chr21_+_42733870 | 12.73 |
ENST00000330714.3
ENST00000436410.1 ENST00000435611.1 |
MX2
|
myxovirus (influenza virus) resistance 2 (mouse) |
chr1_+_158801095 | 12.70 |
ENST00000368141.4
|
MNDA
|
myeloid cell nuclear differentiation antigen |
chr16_+_12059050 | 12.64 |
ENST00000396495.3
|
TNFRSF17
|
tumor necrosis factor receptor superfamily, member 17 |
chr6_+_32821924 | 11.91 |
ENST00000374859.2
ENST00000453265.2 |
PSMB9
|
proteasome (prosome, macropain) subunit, beta type, 9 |
chr12_+_113376157 | 11.87 |
ENST00000228928.7
|
OAS3
|
2'-5'-oligoadenylate synthetase 3, 100kDa |
chr20_-_56195449 | 11.80 |
ENST00000541799.1
|
ZBP1
|
Z-DNA binding protein 1 |
chr3_+_187086120 | 11.44 |
ENST00000259030.2
|
RTP4
|
receptor (chemosensory) transporter protein 4 |
chr1_+_12227035 | 11.06 |
ENST00000376259.3
ENST00000536782.1 |
TNFRSF1B
|
tumor necrosis factor receptor superfamily, member 1B |
chr15_+_45003675 | 10.79 |
ENST00000558401.1
ENST00000559916.1 ENST00000544417.1 |
B2M
|
beta-2-microglobulin |
chr6_+_26365443 | 10.77 |
ENST00000527422.1
ENST00000356386.2 ENST00000396934.3 ENST00000377708.2 ENST00000396948.1 ENST00000508906.2 |
BTN3A2
|
butyrophilin, subfamily 3, member A2 |
chr1_+_79086088 | 10.66 |
ENST00000370751.5
ENST00000342282.3 |
IFI44L
|
interferon-induced protein 44-like |
chr3_-_49851313 | 10.54 |
ENST00000333486.3
|
UBA7
|
ubiquitin-like modifier activating enzyme 7 |
chr8_+_27184320 | 10.51 |
ENST00000522517.1
|
PTK2B
|
protein tyrosine kinase 2 beta |
chr4_-_76944621 | 10.49 |
ENST00000306602.1
|
CXCL10
|
chemokine (C-X-C motif) ligand 10 |
chr12_+_94542459 | 10.10 |
ENST00000258526.4
|
PLXNC1
|
plexin C1 |
chr11_-_104905840 | 9.95 |
ENST00000526568.1
ENST00000393136.4 ENST00000531166.1 ENST00000534497.1 ENST00000527979.1 ENST00000446369.1 ENST00000353247.5 ENST00000528974.1 ENST00000533400.1 ENST00000525825.1 ENST00000436863.3 |
CASP1
|
caspase 1, apoptosis-related cysteine peptidase |
chr6_+_26365387 | 9.93 |
ENST00000532865.1
ENST00000530653.1 ENST00000527417.1 |
BTN3A2
|
butyrophilin, subfamily 3, member A2 |
chr2_+_7017796 | 9.92 |
ENST00000382040.3
|
RSAD2
|
radical S-adenosyl methionine domain containing 2 |
chr22_+_39436862 | 9.80 |
ENST00000381565.2
ENST00000452957.2 |
APOBEC3F
APOBEC3G
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3F apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3G |
chr6_+_6588902 | 9.78 |
ENST00000230568.4
|
LY86
|
lymphocyte antigen 86 |
chr1_+_948803 | 9.69 |
ENST00000379389.4
|
ISG15
|
ISG15 ubiquitin-like modifier |
chr11_+_124932986 | 9.56 |
ENST00000407458.1
ENST00000298280.5 |
SLC37A2
|
solute carrier family 37 (glucose-6-phosphate transporter), member 2 |
chr9_-_100881466 | 9.55 |
ENST00000341469.2
ENST00000342043.3 ENST00000375098.3 |
TRIM14
|
tripartite motif containing 14 |
chr11_+_124933191 | 9.46 |
ENST00000532000.1
ENST00000308074.4 |
SLC37A2
|
solute carrier family 37 (glucose-6-phosphate transporter), member 2 |
chr17_-_4643161 | 9.38 |
ENST00000574412.1
|
CXCL16
|
chemokine (C-X-C motif) ligand 16 |
chr14_-_67955426 | 9.37 |
ENST00000554480.1
|
TMEM229B
|
transmembrane protein 229B |
chr3_-_27764190 | 9.25 |
ENST00000537516.1
|
EOMES
|
eomesodermin |
chr20_-_56195525 | 9.15 |
ENST00000371173.3
ENST00000395822.3 ENST00000340462.4 ENST00000343535.4 |
ZBP1
|
Z-DNA binding protein 1 |
chr6_-_32821599 | 9.14 |
ENST00000354258.4
|
TAP1
|
transporter 1, ATP-binding cassette, sub-family B (MDR/TAP) |
chr6_+_116782527 | 9.12 |
ENST00000368606.3
ENST00000368605.1 |
FAM26F
|
family with sequence similarity 26, member F |
chr12_+_40618764 | 9.12 |
ENST00000343742.2
|
LRRK2
|
leucine-rich repeat kinase 2 |
chr6_+_26440700 | 9.01 |
ENST00000494393.1
ENST00000482451.1 ENST00000244519.2 ENST00000339789.4 ENST00000471353.1 ENST00000361232.3 ENST00000487627.1 ENST00000496719.1 ENST00000490254.1 ENST00000487272.1 |
BTN3A3
|
butyrophilin, subfamily 3, member A3 |
chr4_-_169401628 | 8.76 |
ENST00000514748.1
ENST00000512371.1 ENST00000260184.7 ENST00000505890.1 ENST00000511577.1 |
DDX60L
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 60-like |
chr2_-_7005785 | 8.74 |
ENST00000256722.5
ENST00000404168.1 ENST00000458098.1 |
CMPK2
|
cytidine monophosphate (UMP-CMP) kinase 2, mitochondrial |
chr13_-_43566301 | 8.68 |
ENST00000398762.3
ENST00000313640.7 ENST00000313624.7 |
EPSTI1
|
epithelial stromal interaction 1 (breast) |
chr6_-_33281979 | 8.64 |
ENST00000426633.2
ENST00000467025.1 |
TAPBP
|
TAP binding protein (tapasin) |
chr11_-_104916034 | 8.61 |
ENST00000528513.1
ENST00000375706.2 ENST00000375704.3 |
CARD16
|
caspase recruitment domain family, member 16 |
chr10_-_91174215 | 8.58 |
ENST00000371837.1
|
LIPA
|
lipase A, lysosomal acid, cholesterol esterase |
chr6_+_32811861 | 8.52 |
ENST00000453426.1
|
TAPSAR1
|
TAP1 and PSMB8 antisense RNA 1 |
chr11_-_60720002 | 8.51 |
ENST00000538739.1
|
SLC15A3
|
solute carrier family 15 (oligopeptide transporter), member 3 |
chr19_+_18284477 | 8.37 |
ENST00000407280.3
|
IFI30
|
interferon, gamma-inducible protein 30 |
chr16_-_11350036 | 8.28 |
ENST00000332029.2
|
SOCS1
|
suppressor of cytokine signaling 1 |
chr16_+_10972818 | 8.15 |
ENST00000576601.1
|
CIITA
|
class II, major histocompatibility complex, transactivator |
chr1_-_89488510 | 8.09 |
ENST00000564665.1
ENST00000370481.4 |
GBP3
|
guanylate binding protein 3 |
chr16_+_85936295 | 8.07 |
ENST00000563180.1
ENST00000564617.1 ENST00000564803.1 |
IRF8
|
interferon regulatory factor 8 |
chr11_-_104972158 | 8.06 |
ENST00000598974.1
ENST00000593315.1 ENST00000594519.1 ENST00000415981.2 ENST00000525374.1 ENST00000375707.1 |
CASP1
CARD16
CARD17
|
caspase 1, apoptosis-related cysteine peptidase caspase recruitment domain family, member 16 caspase recruitment domain family, member 17 |
chr15_+_89182156 | 8.05 |
ENST00000379224.5
|
ISG20
|
interferon stimulated exonuclease gene 20kDa |
chr6_-_33282163 | 8.04 |
ENST00000434618.2
ENST00000456592.2 |
TAPBP
|
TAP binding protein (tapasin) |
chr7_-_92777606 | 7.98 |
ENST00000437805.1
ENST00000446959.1 ENST00000439952.1 ENST00000414791.1 ENST00000446033.1 ENST00000411955.1 ENST00000318238.4 |
SAMD9L
|
sterile alpha motif domain containing 9-like |
chr6_-_33282024 | 7.96 |
ENST00000475304.1
ENST00000489157.1 |
TAPBP
|
TAP binding protein (tapasin) |
chr2_+_7005959 | 7.95 |
ENST00000442639.1
|
RSAD2
|
radical S-adenosyl methionine domain containing 2 |
chr8_-_79717163 | 7.82 |
ENST00000520269.1
|
IL7
|
interleukin 7 |
chr10_+_91087651 | 7.73 |
ENST00000371818.4
|
IFIT3
|
interferon-induced protein with tetratricopeptide repeats 3 |
chr22_-_17700260 | 7.68 |
ENST00000399837.2
ENST00000543038.1 |
CECR1
|
cat eye syndrome chromosome region, candidate 1 |
chr6_+_26402517 | 7.65 |
ENST00000414912.2
|
BTN3A1
|
butyrophilin, subfamily 3, member A1 |
chr15_+_89182178 | 7.56 |
ENST00000559876.1
|
ISG20
|
interferon stimulated exonuclease gene 20kDa |
chr11_+_5711010 | 7.53 |
ENST00000454828.1
|
TRIM22
|
tripartite motif containing 22 |
chr15_+_89181974 | 7.47 |
ENST00000306072.5
|
ISG20
|
interferon stimulated exonuclease gene 20kDa |
chr6_+_26402465 | 7.45 |
ENST00000476549.2
ENST00000289361.6 ENST00000450085.2 ENST00000425234.2 ENST00000427334.1 ENST00000506698.1 |
BTN3A1
|
butyrophilin, subfamily 3, member A1 |
chr19_+_1077393 | 7.37 |
ENST00000590577.1
|
HMHA1
|
histocompatibility (minor) HA-1 |
chr3_+_122399697 | 7.36 |
ENST00000494811.1
|
PARP14
|
poly (ADP-ribose) polymerase family, member 14 |
chr17_+_25958174 | 7.36 |
ENST00000313648.6
ENST00000577392.1 ENST00000584661.1 ENST00000413914.2 |
LGALS9
|
lectin, galactoside-binding, soluble, 9 |
chr4_+_147096837 | 7.25 |
ENST00000296581.5
ENST00000502781.1 |
LSM6
|
LSM6 homolog, U6 small nuclear RNA associated (S. cerevisiae) |
chr5_+_96211643 | 7.23 |
ENST00000437043.3
ENST00000510373.1 |
ERAP2
|
endoplasmic reticulum aminopeptidase 2 |
chr8_+_144640499 | 7.16 |
ENST00000525721.1
ENST00000534018.1 |
GSDMD
|
gasdermin D |
chr6_+_32811885 | 7.08 |
ENST00000458296.1
ENST00000413039.1 ENST00000429600.1 ENST00000412095.1 ENST00000415067.1 ENST00000395330.1 |
TAPSAR1
PSMB9
|
TAP1 and PSMB8 antisense RNA 1 proteasome (prosome, macropain) subunit, beta type, 9 |
chr9_+_5450503 | 7.03 |
ENST00000381573.4
ENST00000381577.3 |
CD274
|
CD274 molecule |
chr1_+_167599532 | 6.95 |
ENST00000537350.1
|
RCSD1
|
RCSD domain containing 1 |
chr1_+_158901329 | 6.93 |
ENST00000368140.1
ENST00000368138.3 ENST00000392254.2 ENST00000392252.3 ENST00000368135.4 |
PYHIN1
|
pyrin and HIN domain family, member 1 |
chr5_+_96212185 | 6.91 |
ENST00000379904.4
|
ERAP2
|
endoplasmic reticulum aminopeptidase 2 |
chr3_+_46449049 | 6.86 |
ENST00000357392.4
ENST00000400880.3 ENST00000433848.1 |
CCRL2
|
chemokine (C-C motif) receptor-like 2 |
chr11_+_60223312 | 6.82 |
ENST00000532491.1
ENST00000532073.1 ENST00000534668.1 ENST00000528313.1 ENST00000533306.1 |
MS4A1
|
membrane-spanning 4-domains, subfamily A, member 1 |
chr11_-_118095718 | 6.82 |
ENST00000526620.1
|
AMICA1
|
adhesion molecule, interacts with CXADR antigen 1 |
chr2_-_231084659 | 6.71 |
ENST00000258381.6
ENST00000358662.4 ENST00000455674.1 ENST00000392048.3 |
SP110
|
SP110 nuclear body protein |
chr4_+_100737954 | 6.66 |
ENST00000296414.7
ENST00000512369.1 |
DAPP1
|
dual adaptor of phosphotyrosine and 3-phosphoinositides |
chr14_-_67981916 | 6.56 |
ENST00000357461.2
|
TMEM229B
|
transmembrane protein 229B |
chr1_-_161039753 | 6.56 |
ENST00000368015.1
|
ARHGAP30
|
Rho GTPase activating protein 30 |
chrX_+_10031499 | 6.53 |
ENST00000454666.1
|
WWC3
|
WWC family member 3 |
chr4_-_169239921 | 6.51 |
ENST00000514995.1
ENST00000393743.3 |
DDX60
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 60 |
chr2_+_202122826 | 6.39 |
ENST00000413726.1
|
CASP8
|
caspase 8, apoptosis-related cysteine peptidase |
chr19_-_18197799 | 6.39 |
ENST00000430026.3
ENST00000593993.2 |
IL12RB1
|
interleukin 12 receptor, beta 1 |
chr12_-_10022735 | 6.39 |
ENST00000228438.2
|
CLEC2B
|
C-type lectin domain family 2, member B |
chr16_-_88851618 | 6.39 |
ENST00000301015.9
|
PIEZO1
|
piezo-type mechanosensitive ion channel component 1 |
chr1_+_158979792 | 6.37 |
ENST00000359709.3
ENST00000430894.2 |
IFI16
|
interferon, gamma-inducible protein 16 |
chr1_-_89531041 | 6.36 |
ENST00000370473.4
|
GBP1
|
guanylate binding protein 1, interferon-inducible |
chr11_+_124932955 | 6.31 |
ENST00000403796.2
|
SLC37A2
|
solute carrier family 37 (glucose-6-phosphate transporter), member 2 |
chr22_+_36044411 | 6.30 |
ENST00000409652.4
|
APOL6
|
apolipoprotein L, 6 |
chr2_-_231084820 | 6.29 |
ENST00000258382.5
ENST00000338556.3 |
SP110
|
SP110 nuclear body protein |
chr8_+_144640477 | 6.29 |
ENST00000262580.4
|
GSDMD
|
gasdermin D |
chr1_+_158149737 | 6.29 |
ENST00000368171.3
|
CD1D
|
CD1d molecule |
chr3_-_172241250 | 6.27 |
ENST00000420541.2
ENST00000241261.2 |
TNFSF10
|
tumor necrosis factor (ligand) superfamily, member 10 |
chr3_+_63897605 | 6.16 |
ENST00000487717.1
|
ATXN7
|
ataxin 7 |
chr2_-_214014959 | 6.13 |
ENST00000442445.1
ENST00000457361.1 ENST00000342002.2 |
IKZF2
|
IKAROS family zinc finger 2 (Helios) |
chr17_+_41363854 | 6.13 |
ENST00000588693.1
ENST00000588659.1 ENST00000541594.1 ENST00000536052.1 ENST00000331615.3 |
TMEM106A
|
transmembrane protein 106A |
chr3_+_122283175 | 6.11 |
ENST00000383661.3
|
DTX3L
|
deltex 3-like (Drosophila) |
chr2_-_231084617 | 6.06 |
ENST00000409815.2
|
SP110
|
SP110 nuclear body protein |
chr11_+_71710648 | 6.06 |
ENST00000260049.5
|
IL18BP
|
interleukin 18 binding protein |
chr15_+_75491213 | 6.06 |
ENST00000360639.2
|
C15orf39
|
chromosome 15 open reading frame 39 |
chr11_-_615942 | 6.05 |
ENST00000397562.3
ENST00000330243.5 ENST00000397570.1 ENST00000397574.2 |
IRF7
|
interferon regulatory factor 7 |
chr11_+_60223225 | 6.00 |
ENST00000524807.1
ENST00000345732.4 |
MS4A1
|
membrane-spanning 4-domains, subfamily A, member 1 |
chr10_+_91174486 | 5.99 |
ENST00000416601.1
|
IFIT5
|
interferon-induced protein with tetratricopeptide repeats 5 |
chr11_-_4414880 | 5.98 |
ENST00000254436.7
ENST00000543625.1 |
TRIM21
|
tripartite motif containing 21 |
chr2_+_163175394 | 5.98 |
ENST00000446271.1
ENST00000429691.2 |
GCA
|
grancalcin, EF-hand calcium binding protein |
chr6_-_32811771 | 5.93 |
ENST00000395339.3
ENST00000374882.3 |
PSMB8
|
proteasome (prosome, macropain) subunit, beta type, 8 |
chr10_+_134210672 | 5.93 |
ENST00000305233.5
ENST00000368609.4 |
PWWP2B
|
PWWP domain containing 2B |
chr17_+_18380051 | 5.93 |
ENST00000581545.1
ENST00000582333.1 ENST00000328114.6 ENST00000412421.2 ENST00000583322.1 ENST00000584941.1 |
LGALS9C
|
lectin, galactoside-binding, soluble, 9C |
chr7_+_140103842 | 5.90 |
ENST00000495590.1
ENST00000275874.5 ENST00000537763.1 |
RAB19
|
RAB19, member RAS oncogene family |
chr16_-_31214051 | 5.87 |
ENST00000350605.4
|
PYCARD
|
PYD and CARD domain containing |
chr11_-_57334732 | 5.86 |
ENST00000526659.1
ENST00000527022.1 |
UBE2L6
|
ubiquitin-conjugating enzyme E2L 6 |
chr8_-_79717750 | 5.86 |
ENST00000263851.4
ENST00000379113.2 |
IL7
|
interleukin 7 |
chr11_+_71710973 | 5.83 |
ENST00000393707.4
|
IL18BP
|
interleukin 18 binding protein |
chr11_-_118095801 | 5.82 |
ENST00000356289.5
|
AMICA1
|
adhesion molecule, interacts with CXADR antigen 1 |
chr15_-_50411412 | 5.77 |
ENST00000284509.6
|
ATP8B4
|
ATPase, class I, type 8B, member 4 |
chr5_-_96143602 | 5.75 |
ENST00000443439.2
ENST00000503921.1 ENST00000508227.1 ENST00000507154.1 |
ERAP1
|
endoplasmic reticulum aminopeptidase 1 |
chr17_-_33864772 | 5.68 |
ENST00000361112.4
|
SLFN12L
|
schlafen family member 12-like |
chr3_+_122399444 | 5.62 |
ENST00000474629.2
|
PARP14
|
poly (ADP-ribose) polymerase family, member 14 |
chr12_+_113376249 | 5.61 |
ENST00000551007.1
ENST00000548514.1 |
OAS3
|
2'-5'-oligoadenylate synthetase 3, 100kDa |
chr5_-_39203093 | 5.58 |
ENST00000515010.1
|
FYB
|
FYN binding protein |
chr11_-_60719213 | 5.53 |
ENST00000227880.3
|
SLC15A3
|
solute carrier family 15 (oligopeptide transporter), member 3 |
chr12_-_49319265 | 5.51 |
ENST00000552878.1
ENST00000453172.2 |
FKBP11
|
FK506 binding protein 11, 19 kDa |
chr13_+_108922228 | 5.51 |
ENST00000542136.1
|
TNFSF13B
|
tumor necrosis factor (ligand) superfamily, member 13b |
chr17_+_47296865 | 5.48 |
ENST00000573347.1
|
ABI3
|
ABI family, member 3 |
chr1_-_161600990 | 5.48 |
ENST00000531221.1
|
FCGR3B
|
Fc fragment of IgG, low affinity IIIb, receptor (CD16b) |
chr12_+_113344811 | 5.47 |
ENST00000551241.1
ENST00000553185.1 ENST00000550689.1 |
OAS1
|
2'-5'-oligoadenylate synthetase 1, 40/46kDa |
chr12_-_53594227 | 5.43 |
ENST00000550743.2
|
ITGB7
|
integrin, beta 7 |
chrX_-_30595959 | 5.40 |
ENST00000378962.3
|
CXorf21
|
chromosome X open reading frame 21 |
chr2_-_89442621 | 5.37 |
ENST00000492167.1
|
IGKV3-20
|
immunoglobulin kappa variable 3-20 |
chr4_-_185395672 | 5.34 |
ENST00000393593.3
|
IRF2
|
interferon regulatory factor 2 |
chr19_-_7766991 | 5.32 |
ENST00000597921.1
ENST00000346664.5 |
FCER2
|
Fc fragment of IgE, low affinity II, receptor for (CD23) |
chr1_+_158979680 | 5.31 |
ENST00000368131.4
ENST00000340979.6 |
IFI16
|
interferon, gamma-inducible protein 16 |
chr16_-_74734672 | 5.28 |
ENST00000306247.7
ENST00000575686.1 |
MLKL
|
mixed lineage kinase domain-like |
chr2_-_191878681 | 5.26 |
ENST00000409465.1
|
STAT1
|
signal transducer and activator of transcription 1, 91kDa |
chr1_-_161039647 | 5.26 |
ENST00000368013.3
|
ARHGAP30
|
Rho GTPase activating protein 30 |
chr2_+_90077680 | 5.17 |
ENST00000390270.2
|
IGKV3D-20
|
immunoglobulin kappa variable 3D-20 |
chr22_-_36556821 | 5.15 |
ENST00000531095.1
ENST00000397293.2 ENST00000349314.2 |
APOL3
|
apolipoprotein L, 3 |
chr4_+_142557717 | 5.15 |
ENST00000320650.4
ENST00000296545.7 |
IL15
|
interleukin 15 |
chr6_-_31324943 | 5.14 |
ENST00000412585.2
ENST00000434333.1 |
HLA-B
|
major histocompatibility complex, class I, B |
chr7_+_18535893 | 5.12 |
ENST00000432645.2
ENST00000441542.2 |
HDAC9
|
histone deacetylase 9 |
chr1_+_158979686 | 5.11 |
ENST00000368132.3
ENST00000295809.7 |
IFI16
|
interferon, gamma-inducible protein 16 |
chr1_-_161600942 | 5.10 |
ENST00000421702.2
|
FCGR3B
|
Fc fragment of IgG, low affinity IIIb, receptor (CD16b) |
chr1_+_247579451 | 5.09 |
ENST00000391828.3
ENST00000366497.2 |
NLRP3
|
NLR family, pyrin domain containing 3 |
chr11_+_71709938 | 5.08 |
ENST00000393705.4
ENST00000337131.5 ENST00000531053.1 ENST00000404792.1 |
IL18BP
|
interleukin 18 binding protein |
chr17_+_78234625 | 5.04 |
ENST00000508628.2
ENST00000582970.1 ENST00000456466.1 ENST00000319921.4 |
RNF213
|
ring finger protein 213 |
chr10_+_91061712 | 5.03 |
ENST00000371826.3
|
IFIT2
|
interferon-induced protein with tetratricopeptide repeats 2 |
chr2_+_120687335 | 5.01 |
ENST00000544261.1
|
PTPN4
|
protein tyrosine phosphatase, non-receptor type 4 (megakaryocyte) |
chr11_-_58980342 | 5.01 |
ENST00000361050.3
|
MPEG1
|
macrophage expressed 1 |
chr11_+_5646213 | 4.98 |
ENST00000429814.2
|
TRIM34
|
tripartite motif containing 34 |
chr12_-_49318715 | 4.95 |
ENST00000444214.2
|
FKBP11
|
FK506 binding protein 11, 19 kDa |
chr2_+_202122703 | 4.95 |
ENST00000447616.1
ENST00000358485.4 |
CASP8
|
caspase 8, apoptosis-related cysteine peptidase |
chr3_+_46448648 | 4.94 |
ENST00000399036.3
|
CCRL2
|
chemokine (C-C motif) receptor-like 2 |
chr5_+_131746575 | 4.91 |
ENST00000337752.2
ENST00000378947.3 ENST00000407797.1 |
C5orf56
|
chromosome 5 open reading frame 56 |
chr4_-_122148620 | 4.91 |
ENST00000509841.1
|
TNIP3
|
TNFAIP3 interacting protein 3 |
chr1_+_27668505 | 4.90 |
ENST00000318074.5
|
SYTL1
|
synaptotagmin-like 1 |
chr14_+_86401039 | 4.89 |
ENST00000557195.1
|
CTD-2341M24.1
|
CTD-2341M24.1 |
chr7_+_134832808 | 4.82 |
ENST00000275767.3
|
TMEM140
|
transmembrane protein 140 |
chr11_+_1874200 | 4.82 |
ENST00000311604.3
|
LSP1
|
lymphocyte-specific protein 1 |
chr15_-_80263506 | 4.80 |
ENST00000335661.6
|
BCL2A1
|
BCL2-related protein A1 |
chr10_+_91152303 | 4.80 |
ENST00000371804.3
|
IFIT1
|
interferon-induced protein with tetratricopeptide repeats 1 |
chrX_+_123095860 | 4.75 |
ENST00000428941.1
|
STAG2
|
stromal antigen 2 |
chr20_+_825275 | 4.72 |
ENST00000541082.1
|
FAM110A
|
family with sequence similarity 110, member A |
chr2_-_191878874 | 4.72 |
ENST00000392322.3
ENST00000392323.2 ENST00000424722.1 ENST00000361099.3 |
STAT1
|
signal transducer and activator of transcription 1, 91kDa |
chr1_-_27998689 | 4.66 |
ENST00000339145.4
ENST00000362020.4 ENST00000361157.6 |
IFI6
|
interferon, alpha-inducible protein 6 |
chr1_+_241695670 | 4.66 |
ENST00000366557.4
|
KMO
|
kynurenine 3-monooxygenase (kynurenine 3-hydroxylase) |
chr14_-_100841794 | 4.65 |
ENST00000556295.1
ENST00000554820.1 |
WARS
|
tryptophanyl-tRNA synthetase |
chr11_-_615570 | 4.64 |
ENST00000525445.1
ENST00000348655.6 ENST00000397566.1 |
IRF7
|
interferon regulatory factor 7 |
chr1_+_79115503 | 4.63 |
ENST00000370747.4
ENST00000438486.1 ENST00000545124.1 |
IFI44
|
interferon-induced protein 44 |
chr11_-_64764435 | 4.61 |
ENST00000534177.1
ENST00000301887.4 |
BATF2
|
basic leucine zipper transcription factor, ATF-like 2 |
chr11_+_5710919 | 4.60 |
ENST00000379965.3
ENST00000425490.1 |
TRIM22
|
tripartite motif containing 22 |
chr10_+_91174314 | 4.55 |
ENST00000371795.4
|
IFIT5
|
interferon-induced protein with tetratricopeptide repeats 5 |
chrX_+_123095546 | 4.46 |
ENST00000371157.3
ENST00000371145.3 ENST00000371144.3 |
STAG2
|
stromal antigen 2 |
chr16_-_28518153 | 4.43 |
ENST00000356897.1
|
IL27
|
interleukin 27 |
chr5_-_96143796 | 4.43 |
ENST00000296754.3
|
ERAP1
|
endoplasmic reticulum aminopeptidase 1 |
chr14_-_67981870 | 4.39 |
ENST00000555994.1
|
TMEM229B
|
transmembrane protein 229B |
chr9_+_4985016 | 4.38 |
ENST00000539801.1
|
JAK2
|
Janus kinase 2 |
chr1_+_241695424 | 4.38 |
ENST00000366558.3
ENST00000366559.4 |
KMO
|
kynurenine 3-monooxygenase (kynurenine 3-hydroxylase) |
chr1_-_25291475 | 4.37 |
ENST00000338888.3
ENST00000399916.1 |
RUNX3
|
runt-related transcription factor 3 |
chr12_+_25205446 | 4.36 |
ENST00000557489.1
ENST00000354454.3 ENST00000536173.1 |
LRMP
|
lymphoid-restricted membrane protein |
chr12_+_113344582 | 4.33 |
ENST00000202917.5
ENST00000445409.2 ENST00000452357.2 |
OAS1
|
2'-5'-oligoadenylate synthetase 1, 40/46kDa |
chr4_-_130014729 | 4.32 |
ENST00000281142.5
ENST00000434680.1 |
SCLT1
|
sodium channel and clathrin linker 1 |
chr17_+_6659153 | 4.30 |
ENST00000441631.1
ENST00000438512.1 ENST00000346752.4 ENST00000361842.3 |
XAF1
|
XIAP associated factor 1 |
chr12_-_32040123 | 4.24 |
ENST00000535163.1
|
RP11-428G5.5
|
RP11-428G5.5 |
chr14_-_65785502 | 4.24 |
ENST00000553754.1
|
CTD-2509G16.5
|
CTD-2509G16.5 |
chr1_-_161600822 | 4.21 |
ENST00000534776.1
ENST00000540048.1 |
FCGR3B
FCGR3A
|
Fc fragment of IgG, low affinity IIIb, receptor (CD16b) Fc fragment of IgG, low affinity IIIa, receptor (CD16a) |
chr4_-_130014532 | 4.20 |
ENST00000506368.1
ENST00000439369.2 ENST00000503215.1 |
SCLT1
|
sodium channel and clathrin linker 1 |
chr2_+_201994569 | 4.16 |
ENST00000457277.1
|
CFLAR
|
CASP8 and FADD-like apoptosis regulator |
chr1_+_113217043 | 4.16 |
ENST00000413052.2
|
MOV10
|
Mov10, Moloney leukemia virus 10, homolog (mouse) |
chr7_-_92747269 | 4.15 |
ENST00000446617.1
ENST00000379958.2 |
SAMD9
|
sterile alpha motif domain containing 9 |
chr2_-_55237484 | 4.07 |
ENST00000394609.2
|
RTN4
|
reticulon 4 |
chr1_+_113217073 | 4.04 |
ENST00000369645.1
|
MOV10
|
Mov10, Moloney leukemia virus 10, homolog (mouse) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
8.2 | 24.6 | GO:0050822 | peptide stabilization(GO:0050822) peptide antigen stabilization(GO:0050823) |
5.8 | 29.2 | GO:1904844 | response to L-glutamine(GO:1904844) cellular response to L-glutamine(GO:1904845) |
4.7 | 18.9 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
4.7 | 52.0 | GO:0019885 | antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
4.6 | 23.1 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
4.3 | 47.8 | GO:0018377 | protein myristoylation(GO:0018377) |
3.7 | 7.4 | GO:0032831 | regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032829) positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032831) |
3.6 | 10.8 | GO:0045062 | extrathymic T cell selection(GO:0045062) |
3.4 | 13.4 | GO:0035915 | pore formation in membrane of other organism(GO:0035915) |
3.1 | 9.3 | GO:0002302 | CD8-positive, alpha-beta T cell differentiation involved in immune response(GO:0002302) |
3.1 | 15.3 | GO:0052056 | modulation by virus of host molecular function(GO:0039506) suppression by virus of host molecular function(GO:0039507) suppression by virus of host catalytic activity(GO:0039513) modulation by virus of host catalytic activity(GO:0039516) suppression by virus of host cysteine-type endopeptidase activity involved in apoptotic process(GO:0039650) negative regulation by symbiont of host catalytic activity(GO:0052053) negative regulation by symbiont of host molecular function(GO:0052056) modulation by symbiont of host catalytic activity(GO:0052148) |
3.0 | 9.1 | GO:1903216 | negative regulation of late endosome to lysosome transport(GO:1902823) regulation of protein processing involved in protein targeting to mitochondrion(GO:1903216) negative regulation of protein processing involved in protein targeting to mitochondrion(GO:1903217) |
3.0 | 17.9 | GO:0034165 | positive regulation of toll-like receptor 9 signaling pathway(GO:0034165) |
2.8 | 30.3 | GO:0045345 | positive regulation of MHC class I biosynthetic process(GO:0045345) |
2.7 | 13.4 | GO:0002636 | positive regulation of germinal center formation(GO:0002636) |
2.6 | 30.9 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
2.5 | 10.0 | GO:0072308 | negative regulation by virus of viral protein levels in host cell(GO:0046725) negative regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072308) |
2.3 | 2.3 | GO:0002590 | regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) negative regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002590) |
2.3 | 13.6 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
2.2 | 8.7 | GO:0009138 | pyrimidine nucleoside diphosphate metabolic process(GO:0009138) |
2.2 | 17.4 | GO:0070383 | DNA cytosine deamination(GO:0070383) |
2.1 | 12.9 | GO:2000110 | negative regulation of macrophage apoptotic process(GO:2000110) |
2.1 | 6.4 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
2.1 | 25.0 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
2.0 | 14.3 | GO:2000538 | regulation of cGMP-mediated signaling(GO:0010752) regulation of B cell chemotaxis(GO:2000537) positive regulation of B cell chemotaxis(GO:2000538) |
2.0 | 11.8 | GO:0006436 | tryptophanyl-tRNA aminoacylation(GO:0006436) |
2.0 | 5.9 | GO:0002277 | myeloid dendritic cell activation involved in immune response(GO:0002277) positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002582) positive regulation of antigen processing and presentation of peptide antigen(GO:0002585) positive regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002588) |
2.0 | 25.4 | GO:1901740 | negative regulation of myoblast fusion(GO:1901740) |
1.8 | 1.8 | GO:0010430 | fatty acid omega-oxidation(GO:0010430) |
1.8 | 3.5 | GO:0046928 | regulation of neurotransmitter secretion(GO:0046928) |
1.7 | 8.4 | GO:0038155 | interleukin-23-mediated signaling pathway(GO:0038155) |
1.6 | 12.9 | GO:0002480 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
1.6 | 18.8 | GO:0002252 | immune effector process(GO:0002252) defense response to virus(GO:0051607) |
1.5 | 1.5 | GO:0035759 | mesangial cell-matrix adhesion(GO:0035759) |
1.5 | 6.1 | GO:0090086 | negative regulation of protein deubiquitination(GO:0090086) |
1.5 | 17.8 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
1.5 | 5.9 | GO:0090290 | positive regulation of osteoclast proliferation(GO:0090290) |
1.5 | 8.7 | GO:0019883 | antigen processing and presentation of endogenous antigen(GO:0019883) |
1.4 | 15.8 | GO:0035279 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
1.4 | 8.3 | GO:0010533 | regulation of activation of Janus kinase activity(GO:0010533) |
1.4 | 5.4 | GO:2000321 | positive regulation of T-helper 17 cell differentiation(GO:2000321) |
1.3 | 6.6 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
1.3 | 9.0 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
1.3 | 17.8 | GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
1.3 | 3.8 | GO:1990108 | protein linear deubiquitination(GO:1990108) |
1.2 | 3.7 | GO:1904596 | regulation of connective tissue replacement involved in inflammatory response wound healing(GO:1904596) negative regulation of connective tissue replacement involved in inflammatory response wound healing(GO:1904597) regulation of advanced glycation end-product receptor activity(GO:1904603) negative regulation of advanced glycation end-product receptor activity(GO:1904604) negative regulation of connective tissue replacement(GO:1905204) |
1.2 | 9.7 | GO:0071494 | cellular response to UV-C(GO:0071494) |
1.2 | 4.8 | GO:0051097 | negative regulation of helicase activity(GO:0051097) |
1.2 | 14.2 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
1.2 | 25.4 | GO:0003373 | dynamin polymerization involved in membrane fission(GO:0003373) dynamin polymerization involved in mitochondrial fission(GO:0003374) |
1.2 | 35.8 | GO:0072643 | interferon-gamma secretion(GO:0072643) |
1.2 | 15.0 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
1.1 | 11.0 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
1.1 | 5.4 | GO:0003366 | cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
1.1 | 4.2 | GO:0005986 | sucrose biosynthetic process(GO:0005986) |
1.1 | 5.3 | GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) positive regulation of interleukin-12 secretion(GO:2001184) |
1.0 | 5.2 | GO:1901545 | cellular response to raffinose(GO:0097403) response to raffinose(GO:1901545) |
1.0 | 3.0 | GO:1900369 | negative regulation of RNA interference(GO:1900369) |
1.0 | 5.0 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
1.0 | 2.9 | GO:0006425 | glutaminyl-tRNA aminoacylation(GO:0006425) |
0.9 | 1.9 | GO:0031296 | B cell costimulation(GO:0031296) |
0.9 | 2.7 | GO:0002881 | negative regulation of chronic inflammatory response to non-antigenic stimulus(GO:0002881) |
0.9 | 21.6 | GO:0010818 | T cell chemotaxis(GO:0010818) |
0.9 | 12.5 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
0.9 | 2.7 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
0.9 | 3.5 | GO:0045209 | MAPK phosphatase export from nucleus(GO:0045208) MAPK phosphatase export from nucleus, leptomycin B sensitive(GO:0045209) |
0.9 | 5.3 | GO:0002925 | positive regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002925) |
0.9 | 2.6 | GO:0002678 | positive regulation of chronic inflammatory response(GO:0002678) |
0.9 | 4.4 | GO:1902724 | mineralocorticoid receptor signaling pathway(GO:0031959) positive regulation of skeletal muscle satellite cell proliferation(GO:1902724) positive regulation of growth factor dependent skeletal muscle satellite cell proliferation(GO:1902728) |
0.9 | 5.2 | GO:0002729 | positive regulation of natural killer cell cytokine production(GO:0002729) |
0.8 | 1.7 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
0.8 | 12.7 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.8 | 1.7 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
0.8 | 3.3 | GO:0042495 | detection of triacyl bacterial lipopeptide(GO:0042495) detection of bacterial lipopeptide(GO:0070340) |
0.8 | 7.4 | GO:1902748 | positive regulation of lens fiber cell differentiation(GO:1902748) |
0.8 | 1.6 | GO:0043380 | regulation of memory T cell differentiation(GO:0043380) |
0.8 | 3.2 | GO:0000415 | negative regulation of histone H3-K36 methylation(GO:0000415) |
0.8 | 15.6 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.8 | 7.8 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) regulation of isomerase activity(GO:0010911) positive regulation of isomerase activity(GO:0010912) regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000371) positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000373) |
0.8 | 16.7 | GO:0090050 | peptidyl-lysine deacetylation(GO:0034983) positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
0.7 | 2.2 | GO:0021569 | rhombomere 3 development(GO:0021569) |
0.7 | 6.7 | GO:1900165 | negative regulation of interleukin-6 secretion(GO:1900165) |
0.7 | 2.2 | GO:1990654 | sebum secreting cell proliferation(GO:1990654) |
0.7 | 0.7 | GO:0097102 | endothelial tip cell fate specification(GO:0097102) |
0.7 | 56.6 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.7 | 0.7 | GO:0060734 | regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:0060734) |
0.7 | 7.0 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
0.7 | 5.5 | GO:1902044 | regulation of Fas signaling pathway(GO:1902044) |
0.7 | 7.5 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) |
0.7 | 6.1 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
0.7 | 3.3 | GO:0045349 | interferon-alpha biosynthetic process(GO:0045349) regulation of interferon-alpha biosynthetic process(GO:0045354) |
0.7 | 2.0 | GO:0033625 | positive regulation of integrin activation(GO:0033625) |
0.6 | 3.2 | GO:0021546 | rhombomere development(GO:0021546) |
0.6 | 2.6 | GO:1903045 | neural crest cell migration involved in sympathetic nervous system development(GO:1903045) |
0.6 | 1.9 | GO:0046968 | peptide antigen transport(GO:0046968) |
0.6 | 4.4 | GO:0045078 | positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
0.6 | 6.8 | GO:2000334 | blood microparticle formation(GO:0072564) regulation of blood microparticle formation(GO:2000332) positive regulation of blood microparticle formation(GO:2000334) |
0.6 | 11.1 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.6 | 2.4 | GO:0071348 | cellular response to interleukin-11(GO:0071348) |
0.6 | 1.7 | GO:0032911 | endodermal cell fate determination(GO:0007493) negative regulation of transforming growth factor beta1 production(GO:0032911) |
0.6 | 8.1 | GO:0044130 | negative regulation of growth of symbiont in host(GO:0044130) |
0.6 | 17.5 | GO:1900116 | extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
0.5 | 2.2 | GO:0021816 | lamellipodium assembly involved in ameboidal cell migration(GO:0003363) extension of a leading process involved in cell motility in cerebral cortex radial glia guided migration(GO:0021816) |
0.5 | 2.2 | GO:0072679 | thymocyte migration(GO:0072679) |
0.5 | 1.6 | GO:0043317 | negative regulation of response to tumor cell(GO:0002835) negative regulation of immune response to tumor cell(GO:0002838) negative regulation of natural killer cell mediated immune response to tumor cell(GO:0002856) negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002859) regulation of cytotoxic T cell degranulation(GO:0043317) negative regulation of cytotoxic T cell degranulation(GO:0043318) |
0.5 | 2.1 | GO:0045591 | positive regulation of regulatory T cell differentiation(GO:0045591) |
0.5 | 10.4 | GO:0097296 | activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097296) |
0.5 | 1.6 | GO:0061386 | closure of optic fissure(GO:0061386) |
0.5 | 3.1 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.5 | 3.1 | GO:1900220 | semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
0.5 | 1.5 | GO:0097676 | histone H3-K36 trimethylation(GO:0097198) histone H3-K36 dimethylation(GO:0097676) |
0.5 | 1.5 | GO:1902997 | regulation of choline O-acetyltransferase activity(GO:1902769) positive regulation of choline O-acetyltransferase activity(GO:1902771) negative regulation of tau-protein kinase activity(GO:1902948) positive regulation of early endosome to recycling endosome transport(GO:1902955) negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902960) negative regulation of neurofibrillary tangle assembly(GO:1902997) negative regulation of aspartic-type peptidase activity(GO:1905246) |
0.5 | 3.5 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
0.5 | 51.4 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
0.5 | 12.3 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
0.5 | 3.9 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
0.5 | 2.4 | GO:1990523 | bone regeneration(GO:1990523) |
0.5 | 1.0 | GO:0034756 | regulation of iron ion transport(GO:0034756) regulation of iron ion transmembrane transport(GO:0034759) |
0.5 | 2.4 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) |
0.5 | 3.3 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.5 | 3.3 | GO:1902162 | mRNA localization resulting in posttranscriptional regulation of gene expression(GO:0010609) regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902162) positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902164) |
0.5 | 6.5 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.5 | 1.9 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
0.5 | 4.5 | GO:0097338 | response to clozapine(GO:0097338) |
0.4 | 3.6 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
0.4 | 6.2 | GO:0010623 | programmed cell death involved in cell development(GO:0010623) |
0.4 | 1.8 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
0.4 | 1.7 | GO:0002501 | peptide antigen assembly with MHC protein complex(GO:0002501) peptide antigen assembly with MHC class II protein complex(GO:0002503) |
0.4 | 1.3 | GO:0033037 | polysaccharide localization(GO:0033037) |
0.4 | 4.8 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.4 | 0.9 | GO:0048295 | positive regulation of isotype switching to IgE isotypes(GO:0048295) |
0.4 | 5.6 | GO:0010529 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
0.4 | 2.1 | GO:0036496 | regulation of translational initiation by eIF2 alpha dephosphorylation(GO:0036496) |
0.4 | 5.1 | GO:2000172 | regulation of branching morphogenesis of a nerve(GO:2000172) |
0.4 | 2.1 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.4 | 0.4 | GO:1901026 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
0.4 | 1.2 | GO:0072356 | chromosome passenger complex localization to kinetochore(GO:0072356) |
0.4 | 11.7 | GO:0002360 | T cell lineage commitment(GO:0002360) |
0.4 | 0.8 | GO:0042986 | positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
0.4 | 1.2 | GO:0036451 | cap mRNA methylation(GO:0036451) |
0.4 | 32.5 | GO:0002260 | lymphocyte homeostasis(GO:0002260) |
0.4 | 4.3 | GO:0071492 | cellular response to UV-A(GO:0071492) |
0.4 | 2.3 | GO:0038112 | interleukin-8-mediated signaling pathway(GO:0038112) |
0.4 | 2.3 | GO:0006581 | acetylcholine catabolic process in synaptic cleft(GO:0001507) acetylcholine catabolic process(GO:0006581) |
0.4 | 1.1 | GO:0035621 | ER to Golgi ceramide transport(GO:0035621) |
0.4 | 2.7 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
0.4 | 2.6 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.4 | 1.9 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
0.4 | 0.7 | GO:0052199 | negative regulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052199) |
0.4 | 0.4 | GO:0050787 | detoxification of mercury ion(GO:0050787) |
0.4 | 2.6 | GO:0000432 | regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) |
0.4 | 1.8 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
0.4 | 2.2 | GO:0070269 | pyroptosis(GO:0070269) |
0.4 | 3.6 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.4 | 3.2 | GO:0045905 | translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
0.4 | 9.5 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.3 | 2.7 | GO:0010166 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.3 | 4.0 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
0.3 | 1.6 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
0.3 | 0.7 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
0.3 | 0.6 | GO:0035992 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.3 | 1.0 | GO:1904924 | negative regulation of mitophagy in response to mitochondrial depolarization(GO:1904924) |
0.3 | 2.2 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
0.3 | 2.2 | GO:0007356 | thorax and anterior abdomen determination(GO:0007356) |
0.3 | 3.8 | GO:0060022 | hard palate development(GO:0060022) |
0.3 | 14.3 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
0.3 | 7.0 | GO:0071474 | cellular hyperosmotic response(GO:0071474) |
0.3 | 2.7 | GO:0048539 | bone marrow development(GO:0048539) |
0.3 | 9.2 | GO:0045332 | phospholipid translocation(GO:0045332) |
0.3 | 2.3 | GO:1902255 | positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
0.3 | 2.0 | GO:0032693 | negative regulation of interleukin-10 production(GO:0032693) |
0.3 | 2.0 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.3 | 2.6 | GO:0060546 | negative regulation of necroptotic process(GO:0060546) protein linear polyubiquitination(GO:0097039) |
0.3 | 1.6 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
0.3 | 19.9 | GO:0070206 | protein trimerization(GO:0070206) |
0.3 | 5.5 | GO:0035456 | response to interferon-beta(GO:0035456) |
0.3 | 4.1 | GO:0031953 | negative regulation of protein autophosphorylation(GO:0031953) |
0.3 | 0.8 | GO:0044333 | Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
0.3 | 1.5 | GO:0007296 | vitellogenesis(GO:0007296) |
0.3 | 1.0 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
0.2 | 0.5 | GO:0019442 | tryptophan catabolic process to acetyl-CoA(GO:0019442) |
0.2 | 1.0 | GO:0060411 | cardiac septum morphogenesis(GO:0060411) |
0.2 | 0.7 | GO:1902173 | negative regulation of keratinocyte apoptotic process(GO:1902173) |
0.2 | 0.5 | GO:0072061 | inner medullary collecting duct development(GO:0072061) |
0.2 | 12.0 | GO:0002756 | MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
0.2 | 1.2 | GO:1904764 | negative regulation of fibril organization(GO:1902904) chaperone-mediated autophagy translocation complex disassembly(GO:1904764) |
0.2 | 0.9 | GO:0045425 | positive regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045425) positive regulation of T-helper 1 cell differentiation(GO:0045627) |
0.2 | 10.5 | GO:0010390 | histone monoubiquitination(GO:0010390) |
0.2 | 0.7 | GO:0002384 | hepatic immune response(GO:0002384) |
0.2 | 0.7 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) |
0.2 | 4.0 | GO:0006030 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.2 | 0.7 | GO:0033385 | geranylgeranyl diphosphate metabolic process(GO:0033385) geranylgeranyl diphosphate biosynthetic process(GO:0033386) |
0.2 | 2.2 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.2 | 0.4 | GO:0036369 | transcription factor catabolic process(GO:0036369) |
0.2 | 2.9 | GO:0038003 | opioid receptor signaling pathway(GO:0038003) |
0.2 | 1.9 | GO:0035655 | interleukin-18-mediated signaling pathway(GO:0035655) cellular response to interleukin-18(GO:0071351) |
0.2 | 1.2 | GO:1903588 | negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903588) |
0.2 | 1.0 | GO:0002415 | immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor(GO:0002415) |
0.2 | 4.4 | GO:0036075 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
0.2 | 1.2 | GO:0030037 | actin filament reorganization involved in cell cycle(GO:0030037) |
0.2 | 0.8 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
0.2 | 0.8 | GO:0016267 | O-glycan processing, core 1(GO:0016267) |
0.2 | 0.4 | GO:0014038 | regulation of Schwann cell differentiation(GO:0014038) |
0.2 | 1.3 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.2 | 16.4 | GO:0032481 | positive regulation of type I interferon production(GO:0032481) |
0.2 | 0.7 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.2 | 1.5 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
0.2 | 2.0 | GO:0033227 | dsRNA transport(GO:0033227) |
0.2 | 0.7 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.2 | 3.5 | GO:0006309 | apoptotic DNA fragmentation(GO:0006309) |
0.2 | 3.4 | GO:0038092 | nodal signaling pathway(GO:0038092) |
0.2 | 8.2 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.2 | 2.3 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.2 | 1.1 | GO:0010225 | response to UV-C(GO:0010225) |
0.2 | 1.1 | GO:0038172 | interleukin-33-mediated signaling pathway(GO:0038172) |
0.2 | 2.6 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.2 | 2.3 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.2 | 1.4 | GO:1904627 | response to phorbol 13-acetate 12-myristate(GO:1904627) cellular response to phorbol 13-acetate 12-myristate(GO:1904628) |
0.2 | 1.4 | GO:0072734 | response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
0.2 | 1.4 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
0.2 | 1.2 | GO:0090309 | positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
0.2 | 0.5 | GO:0021775 | smoothened signaling pathway involved in ventral spinal cord interneuron specification(GO:0021775) smoothened signaling pathway involved in spinal cord motor neuron cell fate specification(GO:0021776) |
0.2 | 1.4 | GO:1902952 | positive regulation of dendritic spine maintenance(GO:1902952) |
0.2 | 3.6 | GO:1902004 | positive regulation of beta-amyloid formation(GO:1902004) |
0.2 | 4.8 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.2 | 9.9 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.2 | 4.2 | GO:0045838 | positive regulation of membrane potential(GO:0045838) |
0.2 | 3.0 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
0.2 | 1.2 | GO:0032971 | regulation of muscle filament sliding(GO:0032971) |
0.2 | 2.0 | GO:2000623 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.2 | 0.7 | GO:0000912 | assembly of actomyosin apparatus involved in cytokinesis(GO:0000912) actomyosin contractile ring assembly(GO:0000915) actomyosin contractile ring organization(GO:0044837) |
0.2 | 2.8 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.2 | 0.8 | GO:0035795 | negative regulation of mitochondrial membrane permeability(GO:0035795) |
0.2 | 1.3 | GO:1904885 | beta-catenin destruction complex assembly(GO:1904885) |
0.2 | 0.3 | GO:0010877 | lipid transport involved in lipid storage(GO:0010877) |
0.2 | 1.1 | GO:1903772 | virus maturation(GO:0019075) regulation of viral budding via host ESCRT complex(GO:1903772) |
0.2 | 1.5 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.2 | 1.2 | GO:0009615 | response to virus(GO:0009615) |
0.2 | 1.2 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.1 | 2.8 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.1 | 1.5 | GO:0000821 | regulation of arginine metabolic process(GO:0000821) |
0.1 | 2.2 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.1 | 5.3 | GO:0032479 | regulation of type I interferon production(GO:0032479) |
0.1 | 7.5 | GO:0043928 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
0.1 | 0.7 | GO:0042357 | thiamine diphosphate metabolic process(GO:0042357) |
0.1 | 0.4 | GO:0007518 | myoblast fate determination(GO:0007518) |
0.1 | 3.2 | GO:0030336 | negative regulation of cell migration(GO:0030336) |
0.1 | 8.5 | GO:0034383 | low-density lipoprotein particle clearance(GO:0034383) |
0.1 | 3.6 | GO:0043555 | regulation of translation in response to stress(GO:0043555) |
0.1 | 0.8 | GO:0008217 | regulation of blood pressure(GO:0008217) |
0.1 | 1.4 | GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
0.1 | 3.0 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
0.1 | 1.2 | GO:0040033 | miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
0.1 | 10.6 | GO:0070098 | chemokine-mediated signaling pathway(GO:0070098) |
0.1 | 1.3 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.1 | 4.1 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
0.1 | 0.4 | GO:0048205 | COPI-coated vesicle budding(GO:0035964) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
0.1 | 0.4 | GO:0060032 | notochord regression(GO:0060032) |
0.1 | 1.8 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.1 | 5.5 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.1 | 0.6 | GO:0043686 | co-translational protein modification(GO:0043686) |
0.1 | 2.6 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.1 | 1.0 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.1 | 0.6 | GO:0035026 | leading edge cell differentiation(GO:0035026) |
0.1 | 0.4 | GO:1903926 | signal transduction involved in intra-S DNA damage checkpoint(GO:0072428) negative regulation of mitotic cell cycle DNA replication(GO:1903464) response to bisphenol A(GO:1903925) cellular response to bisphenol A(GO:1903926) |
0.1 | 4.0 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.1 | 1.7 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.1 | 1.9 | GO:0010867 | positive regulation of triglyceride biosynthetic process(GO:0010867) |
0.1 | 0.8 | GO:0051510 | regulation of unidimensional cell growth(GO:0051510) negative regulation of unidimensional cell growth(GO:0051511) establishment of cell polarity regulating cell shape(GO:0071964) regulation of establishment or maintenance of cell polarity regulating cell shape(GO:2000769) positive regulation of establishment or maintenance of cell polarity regulating cell shape(GO:2000771) regulation of establishment of cell polarity regulating cell shape(GO:2000782) positive regulation of establishment of cell polarity regulating cell shape(GO:2000784) positive regulation of barbed-end actin filament capping(GO:2000814) |
0.1 | 2.5 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.1 | 1.9 | GO:0070232 | regulation of T cell apoptotic process(GO:0070232) |
0.1 | 0.6 | GO:1990418 | response to insulin-like growth factor stimulus(GO:1990418) |
0.1 | 0.4 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
0.1 | 0.2 | GO:0006447 | regulation of translational initiation by iron(GO:0006447) positive regulation of translational initiation by iron(GO:0045994) |
0.1 | 3.2 | GO:0003094 | glomerular filtration(GO:0003094) |
0.1 | 4.0 | GO:0046627 | negative regulation of insulin receptor signaling pathway(GO:0046627) |
0.1 | 0.2 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
0.1 | 2.9 | GO:0036344 | platelet morphogenesis(GO:0036344) |
0.1 | 0.3 | GO:0048075 | positive regulation of eye pigmentation(GO:0048075) |
0.1 | 1.3 | GO:0071502 | cellular response to temperature stimulus(GO:0071502) |
0.1 | 1.1 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
0.1 | 0.7 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.1 | 2.9 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
0.1 | 2.4 | GO:0097264 | self proteolysis(GO:0097264) |
0.1 | 0.5 | GO:1904977 | lymphatic endothelial cell migration(GO:1904977) |
0.1 | 9.8 | GO:0060333 | interferon-gamma-mediated signaling pathway(GO:0060333) |
0.1 | 0.3 | GO:0052331 | hemolysis by symbiont of host erythrocytes(GO:0019836) hemolysis in other organism(GO:0044179) hemolysis in other organism involved in symbiotic interaction(GO:0052331) |
0.1 | 10.4 | GO:0002223 | stimulatory C-type lectin receptor signaling pathway(GO:0002223) |
0.1 | 2.5 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.1 | 1.2 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.1 | 1.0 | GO:0090204 | protein localization to nuclear pore(GO:0090204) |
0.1 | 6.9 | GO:0002456 | T cell mediated immunity(GO:0002456) |
0.1 | 15.6 | GO:0006903 | vesicle targeting(GO:0006903) |
0.1 | 0.6 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
0.1 | 1.2 | GO:0072718 | response to cisplatin(GO:0072718) |
0.1 | 1.1 | GO:0002475 | antigen processing and presentation via MHC class Ib(GO:0002475) |
0.1 | 1.1 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) negative regulation of muscle hypertrophy(GO:0014741) |
0.1 | 1.1 | GO:0018103 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.1 | 0.8 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.1 | 27.3 | GO:0042157 | lipoprotein metabolic process(GO:0042157) |
0.1 | 1.2 | GO:0030091 | protein repair(GO:0030091) |
0.1 | 2.8 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.1 | 0.8 | GO:1901341 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.1 | 1.1 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) |
0.1 | 0.5 | GO:0060754 | positive regulation of mast cell chemotaxis(GO:0060754) |
0.1 | 0.4 | GO:1901842 | negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
0.1 | 12.3 | GO:0038095 | Fc-epsilon receptor signaling pathway(GO:0038095) |
0.1 | 0.9 | GO:0072520 | seminiferous tubule development(GO:0072520) |
0.1 | 1.2 | GO:0033015 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.1 | 0.7 | GO:0010886 | positive regulation of cholesterol storage(GO:0010886) |
0.1 | 0.3 | GO:0021538 | epithalamus development(GO:0021538) habenula development(GO:0021986) |
0.1 | 0.7 | GO:0048168 | regulation of neuronal synaptic plasticity(GO:0048168) |
0.1 | 0.7 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
0.1 | 2.6 | GO:0071353 | cellular response to interleukin-4(GO:0071353) |
0.1 | 0.2 | GO:1902950 | negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) regulation of dendritic spine maintenance(GO:1902950) negative regulation of dendritic spine maintenance(GO:1902951) |
0.1 | 0.4 | GO:0006657 | CDP-choline pathway(GO:0006657) |
0.1 | 2.5 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.1 | 0.4 | GO:1904751 | positive regulation of protein localization to nucleolus(GO:1904751) |
0.1 | 1.0 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.1 | 0.4 | GO:0042335 | cuticle development(GO:0042335) |
0.1 | 0.6 | GO:0045634 | regulation of melanocyte differentiation(GO:0045634) |
0.1 | 5.4 | GO:0051092 | positive regulation of NF-kappaB transcription factor activity(GO:0051092) |
0.1 | 0.6 | GO:0019896 | axonal transport of mitochondrion(GO:0019896) |
0.1 | 0.4 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
0.1 | 0.5 | GO:0090234 | regulation of kinetochore assembly(GO:0090234) |
0.1 | 1.7 | GO:0015671 | oxygen transport(GO:0015671) |
0.1 | 0.5 | GO:0060751 | epithelial cell proliferation involved in mammary gland duct elongation(GO:0060750) branch elongation involved in mammary gland duct branching(GO:0060751) |
0.1 | 0.2 | GO:0031204 | posttranslational protein targeting to membrane, translocation(GO:0031204) |
0.1 | 0.4 | GO:0043248 | proteasome assembly(GO:0043248) |
0.1 | 0.5 | GO:0032910 | transforming growth factor beta3 production(GO:0032907) regulation of transforming growth factor beta3 production(GO:0032910) positive regulation of transforming growth factor beta3 production(GO:0032916) chemotaxis to arachidonic acid(GO:0034670) response to arachidonic acid(GO:1904550) |
0.1 | 1.0 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
0.1 | 0.4 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.1 | 0.8 | GO:0009651 | response to salt stress(GO:0009651) |
0.1 | 0.4 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
0.1 | 1.6 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
0.1 | 0.6 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
0.1 | 1.2 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) |
0.1 | 0.6 | GO:0045779 | negative regulation of bone resorption(GO:0045779) negative regulation of bone remodeling(GO:0046851) |
0.1 | 1.5 | GO:1903392 | negative regulation of focal adhesion assembly(GO:0051895) negative regulation of adherens junction organization(GO:1903392) |
0.1 | 0.8 | GO:0060315 | negative regulation of ryanodine-sensitive calcium-release channel activity(GO:0060315) |
0.1 | 0.8 | GO:0014894 | response to stimulus involved in regulation of muscle adaptation(GO:0014874) response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
0.1 | 0.2 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.1 | 2.1 | GO:0006275 | regulation of DNA replication(GO:0006275) |
0.1 | 1.6 | GO:0048934 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.1 | 3.3 | GO:0006968 | cellular defense response(GO:0006968) |
0.1 | 0.6 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
0.1 | 0.6 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.1 | 0.5 | GO:0035973 | aggrephagy(GO:0035973) |
0.1 | 0.2 | GO:1904017 | cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
0.1 | 1.3 | GO:0097194 | execution phase of apoptosis(GO:0097194) |
0.1 | 0.6 | GO:0007229 | integrin-mediated signaling pathway(GO:0007229) |
0.1 | 0.5 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.1 | 0.5 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
0.1 | 0.2 | GO:0009224 | CMP salvage(GO:0006238) CMP biosynthetic process(GO:0009224) CMP metabolic process(GO:0046035) |
0.1 | 0.5 | GO:0019264 | glycine biosynthetic process from serine(GO:0019264) |
0.1 | 1.1 | GO:2000107 | negative regulation of leukocyte apoptotic process(GO:2000107) |
0.1 | 0.4 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
0.1 | 11.7 | GO:0019083 | viral transcription(GO:0019083) |
0.1 | 7.3 | GO:0090630 | activation of GTPase activity(GO:0090630) |
0.1 | 0.8 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.0 | 0.2 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
0.0 | 1.0 | GO:0006828 | manganese ion transport(GO:0006828) |
0.0 | 0.7 | GO:0010990 | regulation of SMAD protein complex assembly(GO:0010990) negative regulation of SMAD protein complex assembly(GO:0010991) |
0.0 | 0.2 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
0.0 | 0.5 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.0 | 0.7 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) V(D)J recombination(GO:0033151) |
0.0 | 2.2 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.0 | 2.1 | GO:0031529 | ruffle organization(GO:0031529) |
0.0 | 2.4 | GO:0006879 | cellular iron ion homeostasis(GO:0006879) |
0.0 | 0.2 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
0.0 | 0.2 | GO:0044857 | plasma membrane raft assembly(GO:0044854) plasma membrane raft organization(GO:0044857) caveola assembly(GO:0070836) |
0.0 | 3.4 | GO:0046847 | filopodium assembly(GO:0046847) |
0.0 | 9.5 | GO:0015992 | proton transport(GO:0015992) |
0.0 | 0.6 | GO:0015866 | ADP transport(GO:0015866) |
0.0 | 0.6 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.0 | 1.1 | GO:0007520 | myoblast fusion(GO:0007520) |
0.0 | 0.1 | GO:0000354 | cis assembly of pre-catalytic spliceosome(GO:0000354) |
0.0 | 0.5 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.0 | 0.6 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
0.0 | 0.2 | GO:0034370 | triglyceride-rich lipoprotein particle remodeling(GO:0034370) very-low-density lipoprotein particle remodeling(GO:0034372) |
0.0 | 0.7 | GO:0007379 | segment specification(GO:0007379) |
0.0 | 1.7 | GO:0048286 | lung alveolus development(GO:0048286) |
0.0 | 0.2 | GO:0071346 | cellular response to interferon-gamma(GO:0071346) |
0.0 | 1.2 | GO:0006491 | N-glycan processing(GO:0006491) |
0.0 | 1.7 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.0 | 1.1 | GO:0015914 | phospholipid transport(GO:0015914) |
0.0 | 1.2 | GO:0061641 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
0.0 | 0.9 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.0 | 0.6 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.0 | 0.1 | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
0.0 | 0.1 | GO:0060151 | peroxisome localization(GO:0060151) microtubule-based peroxisome localization(GO:0060152) |
0.0 | 0.8 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.0 | 0.7 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.0 | 1.2 | GO:0051972 | regulation of telomerase activity(GO:0051972) |
0.0 | 16.4 | GO:0043312 | neutrophil activation involved in immune response(GO:0002283) neutrophil degranulation(GO:0043312) |
0.0 | 0.9 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
0.0 | 1.0 | GO:0045737 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) |
0.0 | 0.4 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.0 | 0.1 | GO:0030225 | macrophage differentiation(GO:0030225) |
0.0 | 0.5 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
0.0 | 0.5 | GO:0016180 | snRNA processing(GO:0016180) |
0.0 | 0.3 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
0.0 | 0.1 | GO:0001783 | B cell apoptotic process(GO:0001783) |
0.0 | 0.5 | GO:0035428 | hexose transmembrane transport(GO:0035428) glucose transmembrane transport(GO:1904659) |
0.0 | 1.4 | GO:0035722 | interleukin-12-mediated signaling pathway(GO:0035722) response to interleukin-12(GO:0070671) cellular response to interleukin-12(GO:0071349) |
0.0 | 0.4 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
0.0 | 0.9 | GO:1904837 | beta-catenin-TCF complex assembly(GO:1904837) |
0.0 | 0.6 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.0 | 0.3 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.0 | 1.6 | GO:0045445 | myoblast differentiation(GO:0045445) |
0.0 | 0.4 | GO:0044259 | collagen catabolic process(GO:0030574) collagen metabolic process(GO:0032963) multicellular organismal macromolecule metabolic process(GO:0044259) |
0.0 | 0.7 | GO:0045786 | negative regulation of cell cycle(GO:0045786) |
0.0 | 0.3 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.0 | 0.3 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.0 | 0.5 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
0.0 | 0.9 | GO:0031532 | actin cytoskeleton reorganization(GO:0031532) |
0.0 | 0.5 | GO:0006743 | ubiquinone metabolic process(GO:0006743) ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
0.0 | 0.1 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
0.0 | 0.3 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
0.0 | 0.6 | GO:0007062 | sister chromatid cohesion(GO:0007062) |
0.0 | 0.1 | GO:0019541 | acetate biosynthetic process(GO:0019413) acetyl-CoA biosynthetic process from acetate(GO:0019427) propionate metabolic process(GO:0019541) propionate biosynthetic process(GO:0019542) |
0.0 | 1.5 | GO:0042058 | regulation of epidermal growth factor receptor signaling pathway(GO:0042058) |
0.0 | 0.3 | GO:0003417 | growth plate cartilage development(GO:0003417) |
0.0 | 0.4 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.0 | 0.9 | GO:0071377 | cellular response to glucagon stimulus(GO:0071377) |
0.0 | 0.7 | GO:1904667 | negative regulation of ubiquitin protein ligase activity(GO:1904667) |
0.0 | 0.4 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.0 | 0.6 | GO:0016577 | histone demethylation(GO:0016577) |
0.0 | 0.6 | GO:0042246 | tissue regeneration(GO:0042246) |
0.0 | 0.2 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
0.0 | 0.6 | GO:0035338 | long-chain fatty-acyl-CoA biosynthetic process(GO:0035338) |
0.0 | 0.2 | GO:0060155 | platelet dense granule organization(GO:0060155) |
0.0 | 0.2 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.0 | 0.2 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
0.0 | 1.0 | GO:0001895 | retina homeostasis(GO:0001895) |
0.0 | 0.1 | GO:0009253 | peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
0.0 | 0.3 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.0 | 0.6 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
0.0 | 0.1 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.0 | 0.1 | GO:0098780 | response to mitochondrial depolarisation(GO:0098780) |
0.0 | 0.1 | GO:0090344 | negative regulation of cell aging(GO:0090344) |
0.0 | 0.8 | GO:0006400 | tRNA modification(GO:0006400) |
0.0 | 0.1 | GO:0030575 | nuclear body organization(GO:0030575) |
0.0 | 1.3 | GO:0000725 | recombinational repair(GO:0000725) |
0.0 | 0.6 | GO:0030641 | regulation of cellular pH(GO:0030641) |
0.0 | 0.1 | GO:0044342 | type B pancreatic cell proliferation(GO:0044342) |
0.0 | 0.1 | GO:1904356 | regulation of telomere maintenance via telomerase(GO:0032210) regulation of telomere maintenance via telomere lengthening(GO:1904356) |
0.0 | 0.1 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.9 | 41.6 | GO:0042825 | TAP complex(GO:0042825) |
4.2 | 37.8 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
3.8 | 26.6 | GO:0097179 | protease inhibitor complex(GO:0097179) |
3.3 | 9.8 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
2.8 | 8.4 | GO:0042022 | interleukin-12 receptor complex(GO:0042022) |
2.6 | 12.8 | GO:0031905 | early endosome lumen(GO:0031905) |
2.3 | 9.1 | GO:0044753 | amphisome(GO:0044753) |
2.2 | 2.2 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
2.1 | 46.4 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
1.8 | 5.4 | GO:0071749 | IgA immunoglobulin complex(GO:0071745) IgA immunoglobulin complex, circulating(GO:0071746) monomeric IgA immunoglobulin complex(GO:0071748) polymeric IgA immunoglobulin complex(GO:0071749) secretory IgA immunoglobulin complex(GO:0071751) |
1.8 | 26.8 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
1.3 | 32.0 | GO:0097342 | ripoptosome(GO:0097342) |
1.3 | 3.9 | GO:0097679 | other organism cytoplasm(GO:0097679) |
1.3 | 7.6 | GO:0008537 | proteasome activator complex(GO:0008537) |
1.2 | 10.6 | GO:0043196 | varicosity(GO:0043196) |
1.1 | 5.4 | GO:0034669 | integrin alpha4-beta7 complex(GO:0034669) |
1.1 | 10.8 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.8 | 15.2 | GO:0071439 | clathrin complex(GO:0071439) |
0.8 | 3.3 | GO:0035354 | Toll-like receptor 1-Toll-like receptor 2 protein complex(GO:0035354) |
0.7 | 3.4 | GO:0036398 | TCR signalosome(GO:0036398) |
0.7 | 2.7 | GO:0030936 | collagen type XIII trimer(GO:0005600) transmembrane collagen trimer(GO:0030936) |
0.6 | 7.2 | GO:0005688 | U6 snRNP(GO:0005688) |
0.5 | 14.3 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.5 | 3.0 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.5 | 1.4 | GO:0005674 | transcription factor TFIIF complex(GO:0005674) |
0.5 | 10.4 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.4 | 2.6 | GO:0071797 | LUBAC complex(GO:0071797) |
0.4 | 4.7 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.4 | 3.1 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.4 | 4.7 | GO:0030870 | Mre11 complex(GO:0030870) |
0.4 | 31.9 | GO:0015030 | Cajal body(GO:0015030) |
0.3 | 1.7 | GO:0042611 | MHC protein complex(GO:0042611) MHC class II protein complex(GO:0042613) |
0.3 | 1.0 | GO:0032002 | interleukin-28 receptor complex(GO:0032002) |
0.3 | 3.9 | GO:0005642 | annulate lamellae(GO:0005642) |
0.3 | 1.9 | GO:0071595 | Nem1-Spo7 phosphatase complex(GO:0071595) |
0.3 | 0.6 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
0.3 | 2.4 | GO:0035692 | macrophage migration inhibitory factor receptor complex(GO:0035692) |
0.3 | 1.8 | GO:0020018 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.3 | 1.2 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.3 | 33.7 | GO:0005811 | lipid particle(GO:0005811) |
0.3 | 3.1 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.2 | 1.2 | GO:0098575 | lumenal side of lysosomal membrane(GO:0098575) |
0.2 | 42.7 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.2 | 0.7 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.2 | 3.6 | GO:0044754 | autolysosome(GO:0044754) |
0.2 | 1.3 | GO:0016035 | zeta DNA polymerase complex(GO:0016035) |
0.2 | 2.4 | GO:0016589 | NURF complex(GO:0016589) |
0.2 | 1.3 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.2 | 1.2 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.2 | 7.2 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.2 | 4.2 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.2 | 1.0 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.2 | 25.4 | GO:0035578 | azurophil granule lumen(GO:0035578) |
0.2 | 2.3 | GO:0032009 | early phagosome(GO:0032009) |
0.2 | 0.4 | GO:0097125 | cyclin B1-CDK1 complex(GO:0097125) |
0.2 | 6.5 | GO:0031528 | microvillus membrane(GO:0031528) |
0.2 | 2.6 | GO:0042587 | glycogen granule(GO:0042587) |
0.2 | 18.7 | GO:0035577 | azurophil granule membrane(GO:0035577) |
0.2 | 1.6 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.2 | 6.1 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.2 | 2.2 | GO:0044327 | dendritic spine head(GO:0044327) |
0.2 | 2.2 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.2 | 4.4 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.2 | 65.4 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.2 | 5.3 | GO:0016580 | Sin3 complex(GO:0016580) |
0.2 | 0.5 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
0.2 | 1.4 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.1 | 7.0 | GO:0030027 | lamellipodium(GO:0030027) |
0.1 | 2.3 | GO:0043083 | synaptic cleft(GO:0043083) |
0.1 | 1.7 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.1 | 0.4 | GO:0031213 | RSF complex(GO:0031213) |
0.1 | 0.5 | GO:0097635 | extrinsic component of autophagosome membrane(GO:0097635) |
0.1 | 17.3 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.1 | 2.4 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.1 | 0.7 | GO:0097165 | nuclear stress granule(GO:0097165) |
0.1 | 16.3 | GO:0005643 | nuclear pore(GO:0005643) |
0.1 | 0.8 | GO:0033391 | chromatoid body(GO:0033391) |
0.1 | 5.9 | GO:0018995 | host(GO:0018995) host cell(GO:0043657) |
0.1 | 10.4 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.1 | 25.5 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.1 | 0.8 | GO:0098791 | Golgi subcompartment(GO:0098791) |
0.1 | 1.8 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.1 | 0.4 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.1 | 1.2 | GO:0042382 | paraspeckles(GO:0042382) |
0.1 | 0.7 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.1 | 0.4 | GO:0071547 | piP-body(GO:0071547) |
0.1 | 1.1 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.1 | 3.8 | GO:0042629 | mast cell granule(GO:0042629) |
0.1 | 6.1 | GO:0001772 | immunological synapse(GO:0001772) |
0.1 | 1.5 | GO:0032432 | actin filament bundle(GO:0032432) |
0.1 | 1.3 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.1 | 2.5 | GO:0031105 | septin complex(GO:0031105) |
0.1 | 2.7 | GO:0031143 | pseudopodium(GO:0031143) |
0.1 | 3.6 | GO:0030057 | desmosome(GO:0030057) |
0.1 | 1.7 | GO:0036020 | endolysosome membrane(GO:0036020) |
0.1 | 0.6 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
0.1 | 3.4 | GO:0034361 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.1 | 0.4 | GO:0000333 | telomerase catalytic core complex(GO:0000333) |
0.1 | 1.1 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.1 | 0.8 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
0.1 | 0.6 | GO:0035061 | interchromatin granule(GO:0035061) |
0.1 | 0.3 | GO:0031085 | BLOC-3 complex(GO:0031085) |
0.1 | 0.8 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.1 | 0.2 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.1 | 0.6 | GO:0033565 | ESCRT-0 complex(GO:0033565) |
0.1 | 2.7 | GO:0031231 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
0.1 | 4.8 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.1 | 11.6 | GO:0016363 | nuclear matrix(GO:0016363) |
0.1 | 0.7 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.1 | 0.5 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.1 | 5.7 | GO:0101003 | ficolin-1-rich granule membrane(GO:0101003) |
0.1 | 1.0 | GO:0044309 | dendritic spine(GO:0043197) neuron spine(GO:0044309) |
0.1 | 40.0 | GO:0016607 | nuclear speck(GO:0016607) |
0.1 | 1.0 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.1 | 2.2 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.1 | 17.3 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
0.1 | 0.8 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
0.1 | 8.7 | GO:0016605 | PML body(GO:0016605) |
0.1 | 3.9 | GO:0099738 | cell cortex region(GO:0099738) |
0.1 | 3.7 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.1 | 1.4 | GO:0005884 | actin filament(GO:0005884) |
0.1 | 0.3 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.1 | 0.7 | GO:0070552 | BRISC complex(GO:0070552) |
0.1 | 5.2 | GO:0031519 | PcG protein complex(GO:0031519) |
0.1 | 0.4 | GO:0030891 | VCB complex(GO:0030891) |
0.1 | 1.2 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.1 | 0.6 | GO:0005579 | membrane attack complex(GO:0005579) |
0.1 | 2.5 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.1 | 0.5 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.1 | 0.9 | GO:0032059 | bleb(GO:0032059) |
0.1 | 0.5 | GO:1990589 | ATF4-CREB1 transcription factor complex(GO:1990589) |
0.1 | 1.2 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.1 | 0.3 | GO:0032437 | cuticular plate(GO:0032437) |
0.1 | 0.4 | GO:0071682 | endocytic vesicle lumen(GO:0071682) |
0.1 | 1.2 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.1 | 1.5 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.1 | 0.4 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.1 | 0.4 | GO:0051233 | spindle midzone(GO:0051233) |
0.1 | 2.4 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.1 | 0.6 | GO:0005943 | phosphatidylinositol 3-kinase complex, class IA(GO:0005943) |
0.0 | 1.0 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.0 | 48.8 | GO:0048471 | perinuclear region of cytoplasm(GO:0048471) |
0.0 | 2.3 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.0 | 0.4 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.0 | 0.6 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.0 | 0.9 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.0 | 21.2 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.0 | 16.5 | GO:0005769 | early endosome(GO:0005769) |
0.0 | 0.5 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
0.0 | 0.7 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.0 | 6.5 | GO:0005903 | brush border(GO:0005903) |
0.0 | 8.3 | GO:0001650 | fibrillar center(GO:0001650) |
0.0 | 8.9 | GO:0010008 | endosome membrane(GO:0010008) |
0.0 | 0.7 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.0 | 2.6 | GO:0032421 | stereocilium bundle(GO:0032421) |
0.0 | 16.1 | GO:0098852 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.0 | 1.4 | GO:0005876 | spindle microtubule(GO:0005876) |
0.0 | 1.4 | GO:0043198 | dendritic shaft(GO:0043198) |
0.0 | 0.9 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.0 | 3.4 | GO:1904724 | tertiary granule lumen(GO:1904724) |
0.0 | 4.6 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.0 | 1.4 | GO:0045171 | intercellular bridge(GO:0045171) |
0.0 | 3.7 | GO:0072562 | blood microparticle(GO:0072562) |
0.0 | 5.5 | GO:0000922 | spindle pole(GO:0000922) |
0.0 | 0.2 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.0 | 0.6 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.0 | 10.3 | GO:0016604 | nuclear body(GO:0016604) |
0.0 | 0.8 | GO:0031527 | filopodium membrane(GO:0031527) |
0.0 | 0.5 | GO:0032039 | integrator complex(GO:0032039) |
0.0 | 3.0 | GO:0005938 | cell cortex(GO:0005938) |
0.0 | 2.8 | GO:0035579 | specific granule membrane(GO:0035579) |
0.0 | 6.9 | GO:0001726 | ruffle(GO:0001726) |
0.0 | 2.9 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.0 | 0.1 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.0 | 3.3 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.0 | 0.5 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.0 | 5.7 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
0.0 | 0.6 | GO:0043025 | neuronal cell body(GO:0043025) |
0.0 | 0.2 | GO:0061617 | MICOS complex(GO:0061617) |
0.0 | 2.0 | GO:0045202 | synapse(GO:0045202) |
0.0 | 0.8 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.0 | 0.6 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.0 | 4.8 | GO:0045111 | intermediate filament cytoskeleton(GO:0045111) |
0.0 | 11.9 | GO:0005813 | centrosome(GO:0005813) |
0.0 | 10.1 | GO:0005635 | nuclear envelope(GO:0005635) |
0.0 | 0.2 | GO:0031209 | SCAR complex(GO:0031209) |
0.0 | 0.1 | GO:0097427 | microtubule bundle(GO:0097427) |
0.0 | 0.8 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.0 | 1.8 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.0 | 0.4 | GO:0097542 | ciliary tip(GO:0097542) |
0.0 | 0.2 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.0 | 4.2 | GO:0009898 | cytoplasmic side of plasma membrane(GO:0009898) |
0.0 | 0.4 | GO:0071339 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.0 | 0.8 | GO:0016592 | mediator complex(GO:0016592) |
0.0 | 0.7 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.0 | 0.1 | GO:0046540 | U4/U6 x U5 tri-snRNP complex(GO:0046540) spliceosomal tri-snRNP complex(GO:0097526) |
0.0 | 83.5 | GO:0005829 | cytosol(GO:0005829) |
0.0 | 0.1 | GO:0000974 | Prp19 complex(GO:0000974) |
0.0 | 0.8 | GO:0005925 | focal adhesion(GO:0005925) |
0.0 | 1.0 | GO:0005768 | endosome(GO:0005768) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
7.7 | 23.1 | GO:0008859 | exoribonuclease II activity(GO:0008859) |
7.2 | 86.7 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
6.5 | 32.5 | GO:0015433 | peptide antigen-transporting ATPase activity(GO:0015433) |
5.7 | 17.0 | GO:0042007 | interleukin-18 binding(GO:0042007) |
4.8 | 24.0 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
3.5 | 10.4 | GO:1904713 | beta-catenin destruction complex binding(GO:1904713) |
3.3 | 13.2 | GO:0046978 | TAP binding(GO:0046977) TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
3.3 | 26.0 | GO:0061513 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
2.8 | 14.0 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
2.8 | 8.4 | GO:0016517 | interleukin-12 receptor activity(GO:0016517) |
2.7 | 13.5 | GO:0047844 | deoxycytidine deaminase activity(GO:0047844) |
2.5 | 10.2 | GO:0005151 | interleukin-1, Type II receptor binding(GO:0005151) |
2.4 | 14.3 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
2.4 | 16.6 | GO:0097199 | cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097199) |
2.3 | 14.0 | GO:0015333 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) |
2.2 | 8.7 | GO:0009041 | uridylate kinase activity(GO:0009041) |
2.0 | 11.8 | GO:0004830 | tryptophan-tRNA ligase activity(GO:0004830) |
2.0 | 5.9 | GO:0032090 | Pyrin domain binding(GO:0032090) |
1.8 | 44.3 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
1.8 | 7.4 | GO:0048030 | disaccharide binding(GO:0048030) |
1.4 | 9.5 | GO:0031849 | olfactory receptor binding(GO:0031849) |
1.2 | 17.3 | GO:0089720 | caspase binding(GO:0089720) |
1.2 | 3.7 | GO:1904599 | advanced glycation end-product binding(GO:1904599) |
1.2 | 3.5 | GO:0004531 | deoxyribonuclease II activity(GO:0004531) |
1.1 | 21.5 | GO:0019864 | IgG binding(GO:0019864) |
1.1 | 8.6 | GO:0004771 | sterol esterase activity(GO:0004771) |
1.1 | 10.7 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
1.1 | 4.2 | GO:0042132 | fructose 1,6-bisphosphate 1-phosphatase activity(GO:0042132) |
1.1 | 10.5 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
1.0 | 13.4 | GO:1901612 | cardiolipin binding(GO:1901612) |
1.0 | 32.7 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
1.0 | 1.0 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
1.0 | 9.0 | GO:0050664 | oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor(GO:0050664) |
1.0 | 5.9 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
1.0 | 2.9 | GO:0004819 | glutamine-tRNA ligase activity(GO:0004819) |
0.9 | 28.7 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) |
0.9 | 2.7 | GO:0016495 | C-X3-C chemokine receptor activity(GO:0016495) |
0.9 | 3.6 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.8 | 7.6 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.7 | 9.7 | GO:0031386 | protein tag(GO:0031386) |
0.7 | 30.5 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.7 | 34.4 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.6 | 1.9 | GO:0005136 | interleukin-4 receptor binding(GO:0005136) |
0.6 | 6.3 | GO:0030883 | lipid antigen binding(GO:0030882) endogenous lipid antigen binding(GO:0030883) exogenous lipid antigen binding(GO:0030884) |
0.6 | 5.5 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.6 | 1.8 | GO:0098770 | FBXO family protein binding(GO:0098770) |
0.6 | 5.3 | GO:0019863 | IgE binding(GO:0019863) |
0.6 | 3.5 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.6 | 27.5 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.6 | 13.0 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.5 | 2.2 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.5 | 4.3 | GO:0031996 | thioesterase binding(GO:0031996) |
0.5 | 3.0 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
0.5 | 18.1 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.5 | 1.0 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
0.5 | 2.9 | GO:0045569 | TRAIL binding(GO:0045569) |
0.5 | 16.7 | GO:0031078 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.5 | 2.8 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.5 | 2.7 | GO:0080019 | fatty-acyl-CoA reductase (alcohol-forming) activity(GO:0080019) |
0.4 | 2.2 | GO:0004556 | alpha-amylase activity(GO:0004556) |
0.4 | 2.6 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.4 | 3.3 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.4 | 1.2 | GO:0030626 | U12 snRNA binding(GO:0030626) |
0.4 | 5.3 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.4 | 1.2 | GO:0004483 | mRNA (nucleoside-2'-O-)-methyltransferase activity(GO:0004483) |
0.4 | 2.3 | GO:0004918 | interleukin-8 receptor activity(GO:0004918) |
0.4 | 14.5 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.4 | 2.7 | GO:0004473 | malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) malate dehydrogenase (decarboxylating) (NADP+) activity(GO:0004473) |
0.4 | 2.3 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
0.3 | 15.4 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
0.3 | 2.0 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.3 | 5.0 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.3 | 0.7 | GO:0034437 | glycoprotein transporter activity(GO:0034437) |
0.3 | 1.3 | GO:0033754 | indoleamine 2,3-dioxygenase activity(GO:0033754) |
0.3 | 3.6 | GO:0045159 | myosin II binding(GO:0045159) |
0.3 | 2.3 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.3 | 7.8 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.3 | 9.2 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.3 | 5.5 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.3 | 4.2 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
0.3 | 1.2 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.3 | 2.9 | GO:0003835 | beta-galactoside alpha-2,6-sialyltransferase activity(GO:0003835) |
0.3 | 9.9 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.3 | 1.2 | GO:0004074 | biliverdin reductase activity(GO:0004074) |
0.3 | 3.8 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.3 | 3.1 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.3 | 5.1 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.3 | 1.7 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.3 | 10.2 | GO:0000339 | RNA cap binding(GO:0000339) |
0.3 | 3.8 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.3 | 16.6 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.3 | 0.8 | GO:0034736 | sterol O-acyltransferase activity(GO:0004772) cholesterol O-acyltransferase activity(GO:0034736) |
0.3 | 1.3 | GO:0050659 | N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity(GO:0050659) |
0.3 | 8.0 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.3 | 5.1 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.2 | 8.7 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.2 | 0.5 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.2 | 7.1 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.2 | 0.7 | GO:0001226 | RNA polymerase II transcription corepressor binding(GO:0001226) |
0.2 | 2.5 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.2 | 1.1 | GO:0097001 | ceramide binding(GO:0097001) |
0.2 | 2.3 | GO:0055104 | ligase inhibitor activity(GO:0055104) ubiquitin ligase inhibitor activity(GO:1990948) |
0.2 | 0.7 | GO:0070119 | ciliary neurotrophic factor binding(GO:0070119) |
0.2 | 4.0 | GO:0004568 | chitinase activity(GO:0004568) |
0.2 | 4.2 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.2 | 4.8 | GO:0051400 | BH domain binding(GO:0051400) |
0.2 | 2.9 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.2 | 27.7 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.2 | 1.2 | GO:0016434 | rRNA (cytosine) methyltransferase activity(GO:0016434) |
0.2 | 0.8 | GO:0051800 | phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity(GO:0051800) |
0.2 | 0.8 | GO:0016263 | glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity(GO:0016263) |
0.2 | 2.1 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
0.2 | 1.5 | GO:0004064 | arylesterase activity(GO:0004064) |
0.2 | 5.2 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.2 | 2.2 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.2 | 4.4 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.2 | 0.4 | GO:0046332 | SMAD binding(GO:0046332) |
0.2 | 1.2 | GO:0004945 | angiotensin receptor activity(GO:0001595) angiotensin type II receptor activity(GO:0004945) |
0.2 | 1.5 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.2 | 0.7 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
0.2 | 1.3 | GO:0035800 | deubiquitinase activator activity(GO:0035800) |
0.2 | 3.5 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.2 | 7.7 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.2 | 3.2 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.2 | 1.6 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.2 | 0.9 | GO:0055077 | gap junction hemi-channel activity(GO:0055077) |
0.2 | 1.2 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.2 | 0.5 | GO:0008441 | 3'(2'),5'-bisphosphate nucleotidase activity(GO:0008441) |
0.2 | 1.1 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.2 | 4.1 | GO:0032183 | SUMO binding(GO:0032183) |
0.2 | 1.1 | GO:0002114 | interleukin-33 receptor activity(GO:0002114) |
0.2 | 1.7 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
0.1 | 0.7 | GO:0070363 | mitochondrial light strand promoter sense binding(GO:0070363) |
0.1 | 7.9 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.1 | 2.2 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.1 | 0.4 | GO:0051500 | D-aminoacyl-tRNA deacylase activity(GO:0051499) D-tyrosyl-tRNA(Tyr) deacylase activity(GO:0051500) |
0.1 | 1.8 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.1 | 9.6 | GO:0019843 | rRNA binding(GO:0019843) |
0.1 | 34.3 | GO:0004386 | helicase activity(GO:0004386) |
0.1 | 0.7 | GO:0004782 | sulfinoalanine decarboxylase activity(GO:0004782) |
0.1 | 1.3 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.1 | 5.8 | GO:0038191 | neuropilin binding(GO:0038191) |
0.1 | 0.8 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.1 | 0.7 | GO:0004161 | dimethylallyltranstransferase activity(GO:0004161) geranyltranstransferase activity(GO:0004337) |
0.1 | 2.3 | GO:0005123 | death receptor binding(GO:0005123) |
0.1 | 1.0 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
0.1 | 6.0 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.1 | 1.7 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.1 | 5.2 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.1 | 2.4 | GO:0001011 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
0.1 | 10.0 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.1 | 6.0 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.1 | 0.2 | GO:0050692 | DBD domain binding(GO:0050692) |
0.1 | 0.8 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
0.1 | 0.5 | GO:0050698 | proteoglycan sulfotransferase activity(GO:0050698) |
0.1 | 3.1 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.1 | 3.4 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.1 | 4.1 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.1 | 1.0 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.1 | 0.6 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.1 | 6.7 | GO:0004520 | endodeoxyribonuclease activity(GO:0004520) |
0.1 | 3.4 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.1 | 1.5 | GO:0003680 | AT DNA binding(GO:0003680) |
0.1 | 2.1 | GO:0005522 | profilin binding(GO:0005522) |
0.1 | 66.3 | GO:0005525 | GTP binding(GO:0005525) |
0.1 | 2.8 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.1 | 0.6 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.1 | 0.7 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.1 | 3.9 | GO:0017166 | vinculin binding(GO:0017166) |
0.1 | 2.6 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.1 | 4.8 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
0.1 | 6.8 | GO:0016667 | oxidoreductase activity, acting on a sulfur group of donors(GO:0016667) |
0.1 | 0.7 | GO:0046790 | virion binding(GO:0046790) |
0.1 | 3.0 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.1 | 1.2 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.1 | 0.8 | GO:0004340 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.1 | 15.7 | GO:0003823 | antigen binding(GO:0003823) |
0.1 | 0.4 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
0.1 | 0.5 | GO:0004793 | glycine hydroxymethyltransferase activity(GO:0004372) threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
0.1 | 0.6 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.1 | 0.4 | GO:0034584 | piRNA binding(GO:0034584) |
0.1 | 2.9 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.1 | 0.4 | GO:0008267 | poly-glutamine tract binding(GO:0008267) |
0.1 | 1.0 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.1 | 2.6 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.1 | 3.3 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.1 | 1.9 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.1 | 2.2 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.1 | 1.0 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.1 | 1.1 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.1 | 0.5 | GO:0043183 | vascular endothelial growth factor receptor 1 binding(GO:0043183) |
0.1 | 11.9 | GO:0001047 | core promoter binding(GO:0001047) |
0.1 | 1.2 | GO:0031701 | angiotensin receptor binding(GO:0031701) type 1 angiotensin receptor binding(GO:0031702) |
0.1 | 1.7 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.1 | 3.0 | GO:0043394 | proteoglycan binding(GO:0043394) |
0.1 | 2.6 | GO:0008143 | poly(A) binding(GO:0008143) |
0.1 | 1.4 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.1 | 0.5 | GO:0009008 | DNA-methyltransferase activity(GO:0009008) |
0.1 | 2.0 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.1 | 0.4 | GO:0008665 | 2'-phosphotransferase activity(GO:0008665) |
0.1 | 1.5 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
0.1 | 1.0 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.1 | 0.8 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
0.1 | 1.1 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.1 | 0.7 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.1 | 4.8 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.1 | 1.6 | GO:0045028 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.1 | 0.5 | GO:0001224 | RNA polymerase II transcription cofactor binding(GO:0001224) |
0.1 | 0.4 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.1 | 1.5 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.1 | 0.3 | GO:0016435 | rRNA (guanine) methyltransferase activity(GO:0016435) |
0.1 | 0.9 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
0.1 | 1.3 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.1 | 1.1 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.1 | 5.8 | GO:1990782 | protein tyrosine kinase binding(GO:1990782) |
0.1 | 25.0 | GO:0030246 | carbohydrate binding(GO:0030246) |
0.1 | 2.3 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.1 | 2.5 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.1 | 8.0 | GO:0019210 | protein kinase inhibitor activity(GO:0004860) kinase inhibitor activity(GO:0019210) |
0.1 | 8.5 | GO:0036459 | thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) |
0.1 | 0.7 | GO:0030957 | Tat protein binding(GO:0030957) |
0.1 | 0.4 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
0.1 | 4.7 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.1 | 0.4 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.1 | 1.1 | GO:0099604 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
0.1 | 2.4 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.1 | 0.4 | GO:0005310 | dicarboxylic acid transmembrane transporter activity(GO:0005310) |
0.1 | 4.8 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.1 | 4.0 | GO:0043130 | ubiquitin binding(GO:0043130) |
0.1 | 1.7 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.1 | 7.4 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.1 | 1.6 | GO:0033558 | histone deacetylase activity(GO:0004407) protein deacetylase activity(GO:0033558) |
0.1 | 2.9 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.1 | 0.5 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.0 | 0.3 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.0 | 0.2 | GO:0031208 | POZ domain binding(GO:0031208) |
0.0 | 4.5 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
0.0 | 2.5 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.0 | 0.3 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.0 | 1.0 | GO:0005548 | phospholipid transporter activity(GO:0005548) |
0.0 | 1.9 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.0 | 0.2 | GO:0010861 | thyroid hormone receptor activator activity(GO:0010861) thyroid hormone receptor coactivator activity(GO:0030375) |
0.0 | 2.1 | GO:0003785 | actin monomer binding(GO:0003785) |
0.0 | 0.3 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.0 | 0.7 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.0 | 0.5 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.0 | 1.8 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.0 | 6.8 | GO:0042393 | histone binding(GO:0042393) |
0.0 | 0.6 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.0 | 0.2 | GO:0047179 | platelet-activating factor acetyltransferase activity(GO:0047179) |
0.0 | 0.2 | GO:1903135 | cupric ion binding(GO:1903135) |
0.0 | 1.0 | GO:0070840 | dynein complex binding(GO:0070840) |
0.0 | 2.7 | GO:0019905 | syntaxin binding(GO:0019905) |
0.0 | 0.6 | GO:0005347 | ATP transmembrane transporter activity(GO:0005347) ADP transmembrane transporter activity(GO:0015217) |
0.0 | 0.3 | GO:0016402 | pristanoyl-CoA oxidase activity(GO:0016402) |
0.0 | 0.3 | GO:0060698 | endoribonuclease inhibitor activity(GO:0060698) |
0.0 | 0.8 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.0 | 1.9 | GO:0003727 | single-stranded RNA binding(GO:0003727) |
0.0 | 0.6 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.0 | 4.0 | GO:0005319 | lipid transporter activity(GO:0005319) |
0.0 | 1.1 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.0 | 0.9 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.0 | 7.6 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.0 | 5.4 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 0.3 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
0.0 | 4.8 | GO:0070851 | growth factor receptor binding(GO:0070851) |
0.0 | 0.2 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.0 | 1.2 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.0 | 1.1 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
0.0 | 0.5 | GO:0003924 | GTPase activity(GO:0003924) |
0.0 | 1.0 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.0 | 0.7 | GO:0044769 | ATPase activity, coupled to transmembrane movement of ions, rotational mechanism(GO:0044769) proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.0 | 0.6 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.0 | 0.4 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.0 | 1.6 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
0.0 | 0.2 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.0 | 3.8 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.0 | 0.8 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.0 | 0.2 | GO:0003756 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.0 | 0.3 | GO:0015643 | toxic substance binding(GO:0015643) |
0.0 | 0.6 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.0 | 0.2 | GO:1902936 | phosphatidylinositol bisphosphate binding(GO:1902936) |
0.0 | 0.2 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.0 | 0.6 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.0 | 0.5 | GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding(GO:0000980) |
0.0 | 0.4 | GO:0005355 | glucose transmembrane transporter activity(GO:0005355) hexose transmembrane transporter activity(GO:0015149) |
0.0 | 1.1 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.0 | 0.5 | GO:0051213 | dioxygenase activity(GO:0051213) |
0.0 | 0.5 | GO:0051117 | ATPase binding(GO:0051117) |
0.0 | 0.5 | GO:0009055 | electron carrier activity(GO:0009055) |
0.0 | 0.8 | GO:0003951 | NAD+ kinase activity(GO:0003951) |
0.0 | 0.6 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.0 | 0.4 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
0.0 | 0.1 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.0 | 0.7 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.0 | 1.1 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) |
0.0 | 0.2 | GO:0044548 | S100 protein binding(GO:0044548) |
0.0 | 1.7 | GO:0019903 | protein phosphatase binding(GO:0019903) |
0.0 | 0.8 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.0 | 0.4 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.0 | 0.4 | GO:0016891 | endoribonuclease activity, producing 5'-phosphomonoesters(GO:0016891) endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters(GO:0016893) |
0.0 | 0.1 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.0 | 2.9 | GO:0030674 | protein binding, bridging(GO:0030674) |
0.0 | 0.3 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.0 | 20.8 | GO:0003723 | RNA binding(GO:0003723) |
0.0 | 0.5 | GO:0044325 | ion channel binding(GO:0044325) |
0.0 | 0.5 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.0 | 14.4 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.8 | 31.1 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.6 | 5.7 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.5 | 17.7 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.5 | 48.1 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.5 | 54.2 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.3 | 10.8 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.3 | 16.1 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.3 | 1.0 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.3 | 12.0 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.3 | 5.1 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.3 | 14.0 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.3 | 12.5 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.2 | 8.4 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.2 | 5.9 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.2 | 21.9 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.2 | 14.2 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.2 | 3.0 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.2 | 19.2 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.2 | 0.7 | ST STAT3 PATHWAY | STAT3 Pathway |
0.2 | 8.0 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.2 | 14.7 | PID PLK1 PATHWAY | PLK1 signaling events |
0.1 | 1.0 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.1 | 5.4 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.1 | 41.4 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.1 | 4.4 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.1 | 0.8 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.1 | 9.1 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.1 | 4.7 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.1 | 4.6 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.1 | 3.8 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.1 | 4.6 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.1 | 8.8 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.1 | 15.5 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.1 | 6.6 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.1 | 19.6 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.1 | 6.7 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.1 | 3.7 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.1 | 5.7 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.1 | 5.7 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.1 | 4.7 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.1 | 1.4 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.1 | 3.8 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.1 | 0.8 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.1 | 4.1 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.1 | 2.5 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.1 | 2.0 | PID ALK1 PATHWAY | ALK1 signaling events |
0.1 | 1.1 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.1 | 2.1 | PID RAS PATHWAY | Regulation of Ras family activation |
0.1 | 1.1 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.0 | 0.4 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.0 | 1.1 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.0 | 0.6 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.0 | 1.2 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.0 | 1.1 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.0 | 1.1 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.0 | 0.5 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.0 | 0.9 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.0 | 2.7 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.0 | 0.2 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.0 | 0.8 | PID ATM PATHWAY | ATM pathway |
0.0 | 1.3 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.0 | 1.7 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.0 | 1.5 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.0 | 0.5 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.0 | 1.9 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.0 | 0.5 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.0 | 0.8 | PID AURORA A PATHWAY | Aurora A signaling |
0.0 | 0.2 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.7 | 26.7 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
2.1 | 213.4 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
1.4 | 29.7 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
1.2 | 41.2 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
1.1 | 9.8 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.9 | 27.8 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.8 | 26.3 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.7 | 48.2 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.7 | 71.7 | REACTOME ANTIGEN PROCESSING CROSS PRESENTATION | Genes involved in Antigen processing-Cross presentation |
0.7 | 50.4 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.6 | 7.9 | REACTOME RIG I MDA5 MEDIATED INDUCTION OF IFN ALPHA BETA PATHWAYS | Genes involved in RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways |
0.5 | 5.1 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.5 | 16.8 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.5 | 10.8 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.4 | 14.1 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.4 | 9.0 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.4 | 0.8 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.4 | 26.5 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.4 | 15.0 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.4 | 12.2 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.3 | 7.5 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.3 | 33.8 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.3 | 5.3 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
0.2 | 10.2 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.2 | 5.2 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.2 | 7.6 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.2 | 0.9 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.2 | 2.2 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.2 | 6.6 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.2 | 8.7 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.2 | 15.3 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.2 | 1.8 | REACTOME P75NTR SIGNALS VIA NFKB | Genes involved in p75NTR signals via NF-kB |
0.2 | 1.2 | REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
0.2 | 10.1 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.1 | 3.1 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.1 | 6.9 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.1 | 2.2 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.1 | 10.6 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.1 | 5.1 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.1 | 19.0 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.1 | 12.3 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
0.1 | 3.3 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.1 | 0.9 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.1 | 4.2 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.1 | 2.5 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.1 | 4.7 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.1 | 1.0 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.1 | 0.7 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.1 | 1.8 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.1 | 2.7 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.1 | 2.9 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.1 | 2.8 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.1 | 4.2 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.1 | 4.1 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.1 | 1.5 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.1 | 24.3 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.1 | 2.0 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.1 | 2.9 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.1 | 1.7 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.1 | 8.0 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |
0.1 | 3.0 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.1 | 3.1 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.1 | 4.2 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.1 | 3.2 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.1 | 2.3 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
0.1 | 2.6 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.1 | 1.4 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.1 | 1.3 | REACTOME VIRAL MESSENGER RNA SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
0.1 | 0.8 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.0 | 1.0 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.0 | 2.1 | REACTOME DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | Genes involved in Downstream Signaling Events Of B Cell Receptor (BCR) |
0.0 | 11.0 | REACTOME CLASS I MHC MEDIATED ANTIGEN PROCESSING PRESENTATION | Genes involved in Class I MHC mediated antigen processing & presentation |
0.0 | 1.0 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.0 | 4.3 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.0 | 0.5 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.0 | 0.8 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.0 | 2.5 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.0 | 1.0 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.0 | 3.8 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.0 | 0.6 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
0.0 | 0.4 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.0 | 1.1 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.0 | 0.4 | REACTOME P53 INDEPENDENT G1 S DNA DAMAGE CHECKPOINT | Genes involved in p53-Independent G1/S DNA damage checkpoint |
0.0 | 1.8 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.0 | 0.6 | REACTOME PERK REGULATED GENE EXPRESSION | Genes involved in PERK regulated gene expression |
0.0 | 3.8 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.0 | 0.6 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.0 | 1.5 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.0 | 0.5 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.0 | 2.3 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
0.0 | 1.2 | REACTOME ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | Genes involved in Activation of ATR in response to replication stress |
0.0 | 3.0 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.0 | 0.7 | REACTOME RNA POL I RNA POL III AND MITOCHONDRIAL TRANSCRIPTION | Genes involved in RNA Polymerase I, RNA Polymerase III, and Mitochondrial Transcription |
0.0 | 0.5 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.0 | 0.7 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.0 | 0.5 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.0 | 0.7 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.0 | 2.6 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.0 | 0.1 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.0 | 0.6 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.0 | 0.4 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.0 | 1.2 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.0 | 0.2 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.0 | 1.0 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.0 | 0.4 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |